Keywords
Last Name
Institution

Carlos Cordon-Cardo

TitlePROFESSOR & CHAIR
InstitutionMount Sinai
DepartmentPathology
Address
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentOncological Sciences

    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentGenetics and Genomic Sciences


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Piovan E, Yu J, Tosello V, Herranz D, Ambesi-Impiombato A, Da Silva AC, Sanchez-Martin M, Perez-Garcia A, Rigo I, Castillo M, Indraccolo S, Cross JR, de Stanchina E, Paietta E, Racevskis J, Rowe JM, Tallman MS, Basso G, Meijerink JP, Cordon-Cardo C, Califano A, Ferrando AA. Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia. Cancer Cell. 2013 Dec 9; 24(6):766-76.
      View in: PubMed
    2. Wang G, Lunardi A, Zhang J, Chen Z, Ala U, Webster KA, Tay Y, Gonzalez-Billalabeitia E, Egia A, Shaffer DR, Carver B, Liu XS, Taulli R, Kuo WP, Nardella C, Signoretti S, Cordon-Cardo C, Gerald WL, Pandolfi PP. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion. Nat Genet. 2013 Jul; 45(7):739-46.
      View in: PubMed
    3. Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, Wang G, Mazzucchelli R, Bianconi M, Stack EC, Lis R, Patnaik A, Cantley LC, Bubley G, Cordon-Cardo C, Gerald WL, Montironi R, Signoretti S, Loda M, Nardella C, Pandolfi PP. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nat Genet. 2013 Jul; 45(7):747-55.
      View in: PubMed
    4. Guijarro MV, Dahiya S, Danielson LS, Segura MF, Vales-Lara FM, Menendez S, Popiolek D, Mittal K, Wei JJ, Zavadil J, Cordon-Cardo C, Pandolfi PP, Hernando E. Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling. Am J Pathol. 2013 Jun; 182(6):2015-27.
      View in: PubMed
    5. Haupt S, Mitchell C, Corneille V, Shortt J, Fox S, Pandolfi PP, Castillo-Martin M, Bonal DM, Cordon-Cardo C, Lozano G, Haupt Y. Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner. Cell Cycle. 2013 Jun 1; 12(11):1722-31.
      View in: PubMed
    6. Donovan MJ, Cordon-Cardo C. Predicting high-risk disease using tissue biomarkers. Curr Opin Urol. 2013 May; 23(3):245-51.
      View in: PubMed
    7. Jia AY, Castillo-Martin M, Domingo-Domenech J, Bonal DM, Sánchez-Carbayo M, Silva JM, Cordon-Cardo C. A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells. Am J Pathol. 2013 Apr; 182(4):1171-9.
      View in: PubMed
    8. Shantha Kumara HM, Grieco MJ, Caballero OL, Su T, Ahmed A, Ritter E, Gnjatic S, Cekic V, Old LJ, Simpson AJ, Cordon-Cardo C, Whelan RL. MAGE-A3 is highly expressed in a subset of colorectal cancer patients. Cancer Immun. 2012; 12:16.
      View in: PubMed
    9. Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, Bonal DM, Charytonowicz E, Gladoun N, de la Iglesia-Vicente J, Petrylak DP, Benson MC, Silva JM, Cordon-Cardo C. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. Cancer Cell. 2012 Sep 11; 22(3):373-88.
      View in: PubMed
    10. Papa A, Cordon-Cardo C, Bernardi R, Pandolfi PP. Compound In Vivo Inactivation of Pml and p53 Uncovers a Functional Interaction in Angiosarcoma Suppression. Genes Cancer. 2012 Sep; 3(9-10):599-603.
      View in: PubMed
    11. Yang Y, Wu J, Demir A, Castillo-Martin M, Melamed RD, Zhang G, Fukunaga-Kanabis M, Perez-Lorenzo R, Zheng B, Silvers DN, Brunner G, Wang S, Rabadan R, Cordon-Cardo C, Celebi JT. GAB2 induces tumor angiogenesis in NRAS-driven melanoma. Oncogene. 2013 Aug 1; 32(31):3627-37.
      View in: PubMed
    12. Zhong M, De Angelo P, Osborne L, Paniz-Mondolfi AE, Geller M, Yang Y, Linehan WM, Merino MJ, Cordon-Cardo C, Cai D. Translocation renal cell carcinomas in adults: a single-institution experience. Am J Surg Pathol. 2012 May; 36(5):654-62.
      View in: PubMed
    13. Subramaniam PS, Whye DW, Efimenko E, Chen J, Tosello V, De Keersmaecker K, Kashishian A, Thompson MA, Castillo M, Cordon-Cardo C, Davé UP, Ferrando A, Lannutti BJ, Diacovo TG. Targeting nonclassical oncogenes for therapy in T-ALL. Cancer Cell. 2012 Apr 17; 21(4):459-72.
      View in: PubMed
    14. Samon JB, Castillo-Martin M, Hadler M, Ambesi-Impiobato A, Paietta E, Racevskis J, Wiernik PH, Rowe JM, Jakubczak J, Randolph S, Cordon-Cardo C, Ferrando AA. Preclinical analysis of the ?-secretase inhibitor PF-03084014 in combination with glucocorticoids in T-cell acute lymphoblastic leukemia. Mol Cancer Ther. 2012 Jul; 11(7):1565-75.
      View in: PubMed
    15. Shen TH, Gladoun N, Castillo-Martin M, Bonal D, Domingo-Domenech J, Charytonowicz D, Cordon-Cardo C. A BAC-based transgenic mouse specifically expresses an inducible Cre in the urothelium. PLoS One. 2012; 7(4):e35243.
      View in: PubMed
    16. Hoffman A, Baxter R, Nasar A, Gardner TR, Kumara S, Cordon-Cardo C, Ahmed A, Newman RA, Zmora O, Whelan RL. Perioperative polyphenon E, a green tea extract, does not affect the wound complication rate in mice after sham laparotomy yet has an inhibitory effect on wound healing. Surg Innov. 2012 Dec; 19(4):399-406.
      View in: PubMed
    17. Puerta-Gil P, García-Baquero R, Jia AY, Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F, Sánchez-Carbayo M. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Am J Pathol. 2012 May; 180(5):1808-15.
      View in: PubMed
    18. Charytonowicz E, Matushansky I, Doménech JD, Castillo-Martín M, Ladanyi M, Cordon-Cardo C, Ziman M. PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation. Clin Transl Oncol. 2012 Mar; 14(3):197-206.
      View in: PubMed
    19. Charytonowicz E, Terry M, Coakley K, Telis L, Remotti F, Cordon-Cardo C, Taub RN, Matushansky I. PPAR? agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma. J Clin Invest. 2012 Mar 1; 122(3):886-98.
      View in: PubMed
    20. Donovan MJ, Costa J, Cordon-Cardo C. Personalized approach to prostate cancer prognosis. Arch Esp Urol. 2011 Oct; 64(8):783-91.
      View in: PubMed
    21. Wosnitzer MS, Domingo-Domenech J, Castillo-Martin M, Ritch C, Mansukhani M, Petrylack DP, Benson MC, McKiernan JM, Cordon-Cardo C. Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy. J Urol. 2011 Nov; 186(5):2094-100.
      View in: PubMed
    22. Chen M, Pratt CP, Zeeman ME, Schultz N, Taylor BS, O'Neill A, Castillo-Martin M, Nowak DG, Naguib A, Grace DM, Murn J, Navin N, Atwal GS, Sander C, Gerald WL, Cordon-Cardo C, Newton AC, Carver BS, Trotman LC. Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. Cancer Cell. 2011 Aug 16; 20(2):173-86.
      View in: PubMed
    23. Donovan MJ, Khan FM, Powell D, Bayer-Zubek V, Cordon-Cardo C, Costa J, Eastham J, Scardino P. Postoperative systems models more accurately predict risk of significant disease progression than standard risk groups and a 10-year postoperative nomogram: potential impact on the receipt of adjuvant therapy after surgery. BJU Int. 2012 Jan; 109(1):40-5.
      View in: PubMed
    24. Donovan MJ, Khan FM, Bayer-Zubek V, Powell D, Costa J, Cordon-Cardo C. A systems-based modelling approach using transurethral resection of the prostate (TURP) specimens yielded incremental prognostic significance to Gleason when predicting long-term outcome in men with localized prostate cancer. BJU Int. 2012 Jan; 109(2):207-13.
      View in: PubMed
    25. Wosnitzer MS, Hruby GW, Murphy AM, Barlow LJ, Cordon-Cardo C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JM. A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer. Cancer. 2012 Jan 15; 118(2):358-64.
      View in: PubMed
    26. Cebrian V, Fierro M, Orenes-Piñero E, Grau L, Moya P, Ecke T, Alvarez M, Gil M, Algaba F, Bellmunt J, Cordon-Cardo C, Catto J, López-Beltrán A, Sánchez-Carbayo M. KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients. Am J Pathol. 2011 Aug; 179(2):540-6.
      View in: PubMed
    27. Charytonowicz E, Matushansky I, Castillo-Martin M, Hricik T, Cordon-Cardo C, Ziman M. Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis. Clin Transl Oncol. 2011 Mar; 13(3):194-203.
      View in: PubMed
    28. Karni-Schmidt O, Castillo-Martin M, Shen TH, HuaiShen T, Gladoun N, Domingo-Domenech J, Sanchez-Carbayo M, Li Y, Lowe S, Prives C, Cordon-Cardo C. Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression. Am J Pathol. 2011 Mar; 178(3):1350-60.
      View in: PubMed
    29. Smith BH, Gazda LS, Conn BL, Jain K, Asina S, Levine DM, Parker TS, Laramore MA, Martis PC, Vinerean HV, David EM, Qiu S, Cordon-Cardo C, Hall RD, Gordon BR, Diehl CH, Stenzel KH, Rubin AL. Three-dimensional culture of mouse renal carcinoma cells in agarose macrobeads selects for a subpopulation of cells with cancer stem cell or cancer progenitor properties. Cancer Res. 2011 Feb 1; 71(3):716-24.
      View in: PubMed
    30. Smith BH, Gazda LS, Conn BL, Jain K, Asina S, Levine DM, Parker TS, Laramore MA, Martis PC, Vinerean HV, David EM, Qiu S, North AJ, Couto CG, Post GS, Waters DJ, Cordon-Cardo C, Hall RD, Gordon BR, Diehl CH, Stenzel KH, Rubin AL. Hydrophilic agarose macrobead cultures select for outgrowth of carcinoma cell populations that can restrict tumor growth. Cancer Res. 2011 Feb 1; 71(3):725-35.
      View in: PubMed
    31. Kim IY, Yan X, Tohme S, Ahmed A, Cordon-Cardo C, Shantha Kumara HM, Kim SK, Whelan RL. CpG ODN, Toll like receptor (TLR)-9 agonist, inhibits metastatic colon adenocarcinoma in a murine hepatic tumor model. J Surg Res. 2012 May 15; 174(2):284-90.
      View in: PubMed
    32. Lunardi A, Gaboli M, Giorgio M, Rivi R, Bygrave A, Antoniou M, Drabek D, Dzierzak E, Fagioli M, Salmena L, Botto M, Cordon-Cardo C, Luzzatto L, Pelicci PG, Grosveld F, Pandolfi PP. A Role for PML in Innate Immunity. Genes Cancer. 2011 Jan; 2(1):10-9.
      View in: PubMed
    33. Powell MJ, Casimiro MC, Cordon-Cardo C, He X, Yeow WS, Wang C, McCue PA, McBurney MW, Pestell RG. Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation. Cancer Res. 2011 Feb 1; 71(3):964-75.
      View in: PubMed
    34. Oh SS, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, He N, Jiang Q, Kheifets L, Le A, Lee YC, Liu S, Lu ML, Mao JT, Morgenstern H, Mu LN, Pantuck A, Papp JC, Park SL, Rao JY, Reuter VE, Tashkin DP, Wang H, You NC, Yu SZ, Zhao JK, Belldegrun A, Zhang ZF. Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers. Int J Cancer. 2010 Nov 1; 127(9):2169-82.
      View in: PubMed
    35. De Keersmaecker K, Real PJ, Gatta GD, Palomero T, Sulis ML, Tosello V, Van Vlierberghe P, Barnes K, Castillo M, Sole X, Hadler M, Lenz J, Aplan PD, Kelliher M, Kee BL, Pandolfi PP, Kappes D, Gounari F, Petrie H, Van der Meulen J, Speleman F, Paietta E, Racevskis J, Wiernik PH, Rowe JM, Soulier J, Avran D, Cavé H, Dastugue N, Raimondi S, Meijerink JP, Cordon-Cardo C, Califano A, Ferrando AA. The TLX1 oncogene drives aneuploidy in T cell transformation. Nat Med. 2010 Nov; 16(11):1321-7.
      View in: PubMed
    36. García-Barros M, Thin TH, Maj J, Cordon-Cardo C, Haimovitz-Friedman A, Fuks Z, Kolesnick R. Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited. Cancer Res. 2010 Oct 15; 70(20):8179-86.
      View in: PubMed
    37. Cordon-Cardo C. Cancer stem cells. Ann Oncol. 2010 Oct; 21 Suppl 7:vii93-4.
      View in: PubMed
    38. Donovan MJ, Costa J, Cordon-Cardo C. Personalized approach to prostate cancer prognosis. Minerva Urol Nefrol. 2010 Sep; 62(3):231-9.
      View in: PubMed
    39. Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C. Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol. 2010 Jul-Aug; 28(4):401-8.
      View in: PubMed
    40. Seager C, Puzio-Kuter AM, Cordon-Cardo C, McKiernan J, Abate-Shen C. Mouse models of human bladder cancer as a tool for drug discovery. Curr Protoc Pharmacol. 2010 Jun; Chapter 14:Unit14.14.
      View in: PubMed
    41. Kabbarah O, Nogueira C, Feng B, Nazarian RM, Bosenberg M, Wu M, Scott KL, Kwong LN, Xiao Y, Cordon-Cardo C, Granter SR, Ramaswamy S, Golub T, Duncan LM, Wagner SN, Brennan C, Chin L. Integrative genome comparison of primary and metastatic melanomas. PLoS One. 2010; 5(5):e10770.
      View in: PubMed
    42. Park SL, Bastani D, Goldstein BY, Chang SC, Cozen W, Cai L, Cordon-Cardo C, Ding B, Greenland S, He N, Hussain SK, Jiang Q, Lee YC, Liu S, Lu ML, Mack TM, Mao JT, Morgenstern H, Mu LN, Oh SS, Pantuck A, Papp JC, Rao J, Reuter VE, Tashkin DP, Wang H, You NC, Yu SZ, Zhao JK, Zhang ZF. Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers. Carcinogenesis. 2010 Jul; 31(7):1264-71.
      View in: PubMed
    43. Lin HK, Chen Z, Wang G, Nardella C, Lee SW, Chan CH, Chan CH, Yang WL, Wang J, Egia A, Nakayama KI, Cordon-Cardo C, Teruya-Feldstein J, Pandolfi PP. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature. 2010 Mar 18; 464(7287):374-9.
      View in: PubMed
    44. Van Vlierberghe P, Palomero T, Khiabanian H, Van der Meulen J, Castillo M, Van Roy N, De Moerloose B, Philippé J, González-García S, Toribio ML, Taghon T, Zuurbier L, Cauwelier B, Harrison CJ, Schwab C, Pisecker M, Strehl S, Langerak AW, Gecz J, Sonneveld E, Pieters R, Paietta E, Rowe JM, Wiernik PH, Benoit Y, Soulier J, Poppe B, Yao X, Cordon-Cardo C, Meijerink J, Rabadan R, Speleman F, Ferrando A. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet. 2010 Apr; 42(4):338-42.
      View in: PubMed
    45. Harris CR, Normart R, Yang Q, Stevenson E, Haffty BG, Ganesan S, Cordon-Cardo C, Levine AJ, Tang LH. Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes. Genes Cancer. 2010 Feb; 1(2):115-24.
      View in: PubMed
    46. Yoshizawa A, Fukuoka J, Shimizu S, Shilo K, Franks TJ, Hewitt SM, Fujii T, Cordon-Cardo C, Jen J, Travis WD. Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer. Clin Cancer Res. 2010 Jan 1; 16(1):240-8.
      View in: PubMed
    47. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, Li QJ, Lowe SW, Hannon GJ, He L. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 2009 Dec 15; 23(24):2839-49.
      View in: PubMed
    48. Seager CM, Puzio-Kuter AM, Patel T, Jain S, Cordon-Cardo C, Mc Kiernan J, Abate-Shen C. Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer. Cancer Prev Res (Phila). 2009 Dec; 2(12):1008-14.
      View in: PubMed
    49. Matushansky I, Charytonowicz E, Mills J, Siddiqi S, Hricik T, Cordon-Cardo C. MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century. Expert Rev Anticancer Ther. 2009 Aug; 9(8):1135-44.
      View in: PubMed
    50. Maurer M, Su T, Saal LH, Koujak S, Hopkins BD, Barkley CR, Wu J, Nandula S, Dutta B, Xie Y, Chin YR, Kim DI, Ferris JS, Gruvberger-Saal SK, Laakso M, Wang X, Memeo L, Rojtman A, Matos T, Yu JS, Cordon-Cardo C, Isola J, Terry MB, Toker A, Mills GB, Zhao JJ, Murty VV, Hibshoosh H, Parsons R. 3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma. Cancer Res. 2009 Aug 1; 69(15):6299-306.
      View in: PubMed
    51. Donovan MJ, Osman I, Khan FM, Vengrenyuk Y, Capodieci P, Koscuiszka M, Anand A, Cordon-Cardo C, Costa J, Scher HI. Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease. BJU Int. 2010 Feb; 105(4):462-7.
      View in: PubMed
    52. Donovan MJ, Costa J, Cordon-Cardo C. Systems pathology: a paradigm shift in the practice of diagnostic and predictive pathology. Cancer. 2009 Jul 1; 115(13 Suppl):3078-84.
      View in: PubMed
    53. Silva JM, Ezhkova E, Silva J, Heart S, Castillo M, Campos Y, Castro V, Bonilla F, Cordon-Cardo C, Muthuswamy SK, Powers S, Fuchs E, Hannon GJ. Cyfip1 is a putative invasion suppressor in epithelial cancers. Cell. 2009 Jun 12; 137(6):1047-61.
      View in: PubMed
    54. Donovan MJ, Khan FM, Fernandez G, Mesa-Tejada R, Sapir M, Zubek VB, Powell D, Fogarasi S, Vengrenyuk Y, Teverovskiy M, Segal MR, Karnes RJ, Gaffey TA, Busch C, Haggman M, Hlavcak P, Freedland SJ, Vollmer RT, Albertsen P, Costa J, Cordon-Cardo C. Personalized prediction of tumor response and cancer progression on prostate needle biopsy. J Urol. 2009 Jul; 182(1):125-32.
      View in: PubMed
    55. Shukla-Dave A, Hricak H, Ishill N, Moskowitz CS, Drobnjak M, Reuter VE, Zakian KL, Scardino PT, Cordon-Cardo C. Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles. Clin Cancer Res. 2009 Jun 1; 15(11):3842-9.
      View in: PubMed
    56. Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, Alimonti A, Nardella C, Varmeh S, Scardino PT, Cordon-Cardo C, Gerald W, Pandolfi PP. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet. 2009 May; 41(5):619-24.
      View in: PubMed
    57. Donovan MJ, Kotsianti A, Bayer-Zubek V, Verbel D, Teverovskiy M, Cordon-Cardo C, Costa J, Greco FA, Hainsworth JD, Parums DV. A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib. Eur J Cancer. 2009 May; 45(8):1518-26.
      View in: PubMed
    58. Puzio-Kuter AM, Castillo-Martin M, Kinkade CW, Wang X, Shen TH, Matos T, Shen MM, Cordon-Cardo C, Abate-Shen C. Inactivation of p53 and Pten promotes invasive bladder cancer. Genes Dev. 2009 Mar 15; 23(6):675-80.
      View in: PubMed
    59. Shukla-Dave A, Hricak H, Ishill NM, Moskowitz CS, Drobnjak M, Reuter VE, Zakian KL, Scardino PT, Cordon-Cardo C. Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer. Radiology. 2009 Mar; 250(3):803-12.
      View in: PubMed
    60. Carver BS, Tran J, Chen Z, Carracedo-Perez A, Alimonti A, Nardella C, Gopalan A, Scardino PT, Cordon-Cardo C, Gerald W, Pandolfi PP. ETS rearrangements and prostate cancer initiation. Nature. 2009 Feb 12; 457(7231):E1; discussion E2-3.
      View in: PubMed
    61. Nardella C, Carracedo A, Alimonti A, Hobbs RM, Clohessy JG, Chen Z, Egia A, Fornari A, Fiorentino M, Loda M, Kozma SC, Thomas G, Cordon-Cardo C, Pandolfi PP. Differential requirement of mTOR in postmitotic tissues and tumorigenesis. Sci Signal. 2009; 2(55):ra2.
      View in: PubMed
    62. Eggener SE, Vickers AJ, Serio AM, Donovan MJ, Khan FM, Bayer-Zubek V, Verbel D, Cordon-Cardo C, Reuter VE, Bianco FJ, Scardino PT. Comparison of models to predict clinical failure after radical prostatectomy. Cancer. 2009 Jan 15; 115(2):303-10.
      View in: PubMed
    63. Real PJ, Tosello V, Palomero T, Castillo M, Hernando E, de Stanchina E, Sulis ML, Barnes K, Sawai C, Homminga I, Meijerink J, Aifantis I, Basso G, Cordon-Cardo C, Ai W, Ferrando A. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med. 2009 Jan; 15(1):50-8.
      View in: PubMed
    64. Aleman A, Cebrian V, Alvarez M, Lopez V, Orenes E, Lopez-Serra L, Algaba F, Bellmunt J, López-Beltrán A, Gonzalez-Peramato P, Cordon-Cardo C, García J, del Muro JG, Esteller M, Sánchez-Carbayo M. Identification of PMF1 methylation in association with bladder cancer progression. Clin Cancer Res. 2008 Dec 15; 14(24):8236-43.
      View in: PubMed
    65. Karni-Schmidt O, Zupnick A, Castillo M, Ahmed A, Matos T, Bouvet P, Cordon-Cardo C, Prives C. p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner. J Cell Sci. 2008 Dec 15; 121(Pt 24):4098-105.
      View in: PubMed
    66. Charytonowicz E, Cordon-Cardo C, Matushansky I, Ziman M. Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? Cancer Lett. 2009 Jul 8; 279(2):126-36.
      View in: PubMed
    67. Park SL, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, Hussain SK, Jiang Q, Liu S, Lu ML, Mao JT, Morgenstern H, Mu LN, Ng LJ, Pantuck A, Rao J, Reuter VE, Tashkin DP, You NC, Yu CQ, Yu SZ, Zhao JK, Belldegrun A, Zhang ZF. Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3193-202.
      View in: PubMed
    68. Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, Gao H, Sun Y, Ouyang X, Gerald WL, Cordon-Cardo C, Abate-Shen C. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. J Clin Invest. 2008 Sep; 118(9):3051-64.
      View in: PubMed
    69. Cordon-Cardo C. Molecular alterations associated with bladder cancer initiation and progression. Scand J Urol Nephrol Suppl. 2008 Sep; (218):154-65.
      View in: PubMed
    70. Donovan MJ, Hamann S, Clayton M, Khan FM, Sapir M, Bayer-Zubek V, Fernandez G, Mesa-Tejada R, Teverovskiy M, Reuter VE, Scardino PT, Cordon-Cardo C. Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy. J Clin Oncol. 2008 Aug 20; 26(24):3923-9.
      View in: PubMed
    71. Nardella C, Chen Z, Salmena L, Carracedo A, Alimonti A, Egia A, Carver B, Gerald W, Cordon-Cardo C, Pandolfi PP. Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events. Genes Dev. 2008 Aug 15; 22(16):2172-7.
      View in: PubMed
    72. Stracker TH, Couto SS, Cordon-Cardo C, Matos T, Petrini JH. Chk2 suppresses the oncogenic potential of DNA replication-associated DNA damage. Mol Cell. 2008 Jul 11; 31(1):21-32.
      View in: PubMed
    73. Xue W, Krasnitz A, Lucito R, Sordella R, Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers S, Zender L, Lowe SW. DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev. 2008 Jun 1; 22(11):1439-44.
      View in: PubMed
    74. Becher OJ, Hambardzumyan D, Fomchenko EI, Momota H, Mainwaring L, Bleau AM, Katz AM, Edgar M, Kenney AM, Cordon-Cardo C, Blasberg RG, Holland EC. Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas. Cancer Res. 2008 Apr 1; 68(7):2241-9.
      View in: PubMed
    75. Matushansky I, Hernando E, Socci ND, Matos T, Mills J, Edgar MA, Schwartz GK, Singer S, Cordon-Cardo C, Maki RG. A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas. Am J Pathol. 2008 Apr; 172(4):1069-80.
      View in: PubMed
    76. Voloshyna I, Besana A, Castillo M, Matos T, Weinstein IB, Mansukhani M, Robinson RB, Cordon-Cardo C, Feinmark SJ. TREK-1 is a novel molecular target in prostate cancer. Cancer Res. 2008 Feb 15; 68(4):1197-203.
      View in: PubMed
    77. Rotolo JA, Maj JG, Feldman R, Ren D, Haimovitz-Friedman A, Cordon-Cardo C, Cheng EH, Kolesnick R, Fuks Z. Bax and Bak do not exhibit functional redundancy in mediating radiation-induced endothelial apoptosis in the intestinal mucosa. Int J Radiat Oncol Biol Phys. 2008 Mar 1; 70(3):804-15.
      View in: PubMed
    78. Matushansky I, Maki RG, Cordon-Cardo C. A context dependent role for Wnt signaling in tumorigenesis and stem cells. Cell Cycle. 2008 Mar 15; 7(6):720-4.
      View in: PubMed
    79. Aleman A, Adrien L, Lopez-Serra L, Cordon-Cardo C, Esteller M, Belbin TJ, Sanchez-Carbayo M. Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays. Br J Cancer. 2008 Jan 29; 98(2):466-73.
      View in: PubMed
    80. Matushansky I, Hernando E, Socci ND, Mills JE, Matos TA, Edgar MA, Singer S, Maki RG, Cordon-Cardo C. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest. 2007 Nov; 117(11):3248-57.
      View in: PubMed
    81. Apostolopoulou K, Pateras IS, Evangelou K, Tsantoulis PK, Liontos M, Kittas C, Tiniakos DG, Kotsinas A, Cordon-Cardo C, Gorgoulis VG. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol. 2007 Nov; 213(3):294-302.
      View in: PubMed
    82. Sanchez-Carbayo M, Socci ND, Richstone L, Corton M, Behrendt N, Wulkfuhle J, Bochner B, Petricoin E, Cordon-Cardo C. Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression. Am J Pathol. 2007 Nov; 171(5):1650-8.
      View in: PubMed
    83. Liu Y, Yeh N, Zhu XH, Leversha M, Cordon-Cardo C, Ghossein R, Singh B, Holland E, Koff A. Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1). EMBO J. 2007 Nov 14; 26(22):4683-93.
      View in: PubMed
    84. Feng Z, Hu W, Teresky AK, Hernando E, Cordon-Cardo C, Levine AJ. Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc Natl Acad Sci U S A. 2007 Oct 16; 104(42):16633-8.
      View in: PubMed
    85. Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, Caparros E, Buteau J, Brown K, Perkins SL, Bhagat G, Agarwal AM, Basso G, Castillo M, Nagase S, Cordon-Cardo C, Parsons R, Zúñiga-Pflücker JC, Dominguez M, Ferrando AA. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med. 2007 Oct; 13(10):1203-10.
      View in: PubMed
    86. Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors. Clin Cancer Res. 2007 Aug 1; 13(15 Pt 1):4511-8.
      View in: PubMed
    87. Ma L, Teruya-Feldstein J, Bonner P, Bernardi R, Franz DN, Witte D, Cordon-Cardo C, Pandolfi PP. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. Cancer Res. 2007 Aug 1; 67(15):7106-12.
      View in: PubMed
    88. Cordon-Cardo C, Kotsianti A, Verbel DA, Teverovskiy M, Capodieci P, Hamann S, Jeffers Y, Clayton M, Elkhettabi F, Khan FM, Sapir M, Bayer-Zubek V, Vengrenyuk Y, Fogarsi S, Saidi O, Reuter VE, Scher HI, Kattan MW, Bianco FJ, Wheeler TM, Ayala GE, Scardino PT, Donovan MJ. Improved prediction of prostate cancer recurrence through systems pathology. J Clin Invest. 2007 Jul; 117(7):1876-83.
      View in: PubMed
    89. Dickins RA, McJunkin K, Hernando E, Premsrirut PK, Krizhanovsky V, Burgess DJ, Kim SY, Cordon-Cardo C, Zender L, Hannon GJ, Lowe SW. Tissue-specific and reversible RNA interference in transgenic mice. Nat Genet. 2007 Jul; 39(7):914-21.
      View in: PubMed
    90. Rabbani F, Koppie TM, Charytonowicz E, Drobnjak M, Bochner BH, Cordon-Cardo C. Prognostic significance of p27Kip1 expression in bladder cancer. BJU Int. 2007 Aug; 100(2):259-63.
      View in: PubMed
    91. Sanchez-Carbayo M, Socci ND, Kirchoff T, Erill N, Offit K, Bochner BH, Cordon-Cardo C. A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer. Clin Cancer Res. 2007 Jun 1; 13(11):3215-20.
      View in: PubMed
    92. Hernando E, Charytonowicz E, Dudas ME, Menendez S, Matushansky I, Mills J, Socci ND, Behrendt N, Ma L, Maki RG, Pandolfi PP, Cordon-Cardo C. The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Nat Med. 2007 Jun; 13(6):748-53.
      View in: PubMed
    93. Scott CL, Gil J, Hernando E, Teruya-Feldstein J, Narita M, Martínez D, Visakorpi T, Mu D, Cordon-Cardo C, Peters G, Beach D, Lowe SW. Role of the chromobox protein CBX7 in lymphomagenesis. Proc Natl Acad Sci U S A. 2007 Mar 27; 104(13):5389-94.
      View in: PubMed
    94. Mo L, Zheng X, Huang HY, Shapiro E, Lepor H, Cordon-Cardo C, Sun TT, Wu XR. Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis. J Clin Invest. 2007 Feb; 117(2):314-25.
      View in: PubMed
    95. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature. 2007 Feb 8; 445(7128):656-60.
      View in: PubMed
    96. Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z, Wang J, Erdjument-Bromage H, Tempst P, Cordon-Cardo C, Pandolfi PP, Jiang X. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell. 2007 Jan 12; 128(1):129-39.
      View in: PubMed
    97. Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts. Cancer Gene Ther. 2007 Mar; 14(3):279-86.
      View in: PubMed
    98. Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H, Pavletich NP, Carver BS, Cordon-Cardo C, Erdjument-Bromage H, Tempst P, Chi SG, Kim HJ, Misteli T, Jiang X, Pandolfi PP. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell. 2007 Jan 12; 128(1):141-56.
      View in: PubMed
    99. König F, Krekeler G, Hönig JF, Cordon-Cardo C, Fischer G, Korabiowska M. Relation between human papillomavirus positivity and p16 expression in head and neck carcinomas--a tissue microarray study. Anticancer Res. 2007 Jan-Feb; 27(1A):283-8.
      View in: PubMed
    100. Saidi O, Cordon-Cardo C, Costa J. Technology insight: will systems pathology replace the pathologist? Nat Clin Pract Urol. 2007 Jan; 4(1):39-45.
      View in: PubMed
    101. Yang YC, Lu ML, Rao JY, Wallerand H, Cai L, Cao W, Pantuck A, Dalbagni G, Reuter V, Figlin RA, Belldegrun A, Cordon-Cardo C, Zhang ZF. Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis. Br J Cancer. 2006 Dec 4; 95(11):1455-8.
      View in: PubMed
    102. Grossman HB, Tangen CM, Cordon-Cardo C, Cote R, Waldman FM, De Vere White RW, Karnad AB, Glode M, Crawford ED. Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: a Southwest Oncology Group Study. Oncol Rep. 2006 Oct; 16(4):807-10.
      View in: PubMed
    103. Maluf FC, Cordon-Cardo C, Verbel DA, Satagopan JM, Boyle MG, Herr H, Bajorin DF. Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment. Ann Oncol. 2006 Nov; 17(11):1677-86.
      View in: PubMed
    104. Brinck U, Schlott T, Störber S, Stachura J, Bortkiewicz P, Nagel WD, Hasse FM, Cordon-Cardo C, Fischer G, Korabiowska M. Alterations of the retinoblastoma and p16 pathway correlate with promoter methylation in malignant fibrous histiocytomas. Anticancer Res. 2006 Sep-Oct; 26(5A):3461-5.
      View in: PubMed
    105. Bernardi R, Guernah I, Jin D, Grisendi S, Alimonti A, Teruya-Feldstein J, Cordon-Cardo C, Simon MC, Rafii S, Pandolfi PP. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature. 2006 Aug 17; 442(7104):779-85.
      View in: PubMed
    106. Wendel HG, Malina A, Zhao Z, Zender L, Kogan SC, Cordon-Cardo C, Pelletier J, Lowe SW. Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo. Cancer Res. 2006 Aug 1; 66(15):7639-46.
      View in: PubMed
    107. Polsky D, Mastorides S, Kim D, Dudas M, Leon L, Leung D, Woodruff JM, Brennan MF, Osman I, Cordon-Cardo C. Altered patterns of RB expression define groups of soft tissue sarcoma patients with distinct biological and clinical behavior. Histol Histopathol. 2006 Jul; 21(7):743-52.
      View in: PubMed
    108. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell. 2006 Jun 30; 125(7):1253-67.
      View in: PubMed
    109. Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B, Brennan C, Hahn WC, Cordon-Cardo C, Wagner SN, Flotte TJ, Duncan LM, Granter SR, Chin L. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell. 2006 Jun 30; 125(7):1269-81.
      View in: PubMed
    110. Jechlinger M, Sommer A, Moriggl R, Seither P, Kraut N, Capodiecci P, Donovan M, Cordon-Cardo C, Beug H, Grünert S. Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest. 2006 Jun; 116(6):1561-70.
      View in: PubMed
    111. Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP. Identification of a tumour suppressor network opposing nuclear Akt function. Nature. 2006 May 25; 441(7092):523-7.
      View in: PubMed
    112. Korabiowska M, Voltmann J, Hönig JF, Bortkiewicz P, König F, Cordon-Cardo C, Jenckel F, Ambrosch P, Fischer G. Altered expression of DNA double-strand repair genes Ku70 and Ku80 in carcinomas of the oral cavity. Anticancer Res. 2006 May-Jun; 26(3A):2101-5.
      View in: PubMed
    113. Muthusamy V, Hobbs C, Nogueira C, Cordon-Cardo C, McKee PH, Chin L, Bosenberg MW. Amplification of CDK4 and MDM2 in malignant melanoma. Genes Chromosomes Cancer. 2006 May; 45(5):447-54.
      View in: PubMed
    114. Ruschenburg I, Vollheim B, Stachura J, Cordon-Cardo C, Korabiowska M. Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours. Anticancer Res. 2006 May-Jun; 26(3A):2107-12.
      View in: PubMed
    115. Korabiowska M, Cordon-Cardo C, Schinagl M, Karaus M, Stachura J, Schulz H, Fischer G. Loss of Ku70/Ku80 expression occurs more frequently in hereditary than in sporadic colorectal tumors. Tissue microarray study. Hum Pathol. 2006 Apr; 37(4):448-52.
      View in: PubMed
    116. Soengas MS, Gerald WL, Cordon-Cardo C, Lazebnik Y, Lowe SW. Apaf-1 expression in malignant melanoma. Cell Death Differ. 2006 Feb; 13(2):352-3.
      View in: PubMed
    117. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol. 2006 Feb 10; 24(5):778-89.
      View in: PubMed
    118. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst P. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest. 2006 Jan; 116(1):271-84.
      View in: PubMed
    119. Sanchez-Carbayo M, Socci ND, Lozano JJ, Haab BB, Cordon-Cardo C. Profiling bladder cancer using targeted antibody arrays. Am J Pathol. 2006 Jan; 168(1):93-103.
      View in: PubMed
    120. Cao W, Cai L, Rao JY, Pantuck A, Lu ML, Dalbagni G, Reuter V, Scher H, Cordon-Cardo C, Figlin RA, Belldegrun A, Zhang ZF. Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer. 2005 Dec 1; 104(11):2400-8.
      View in: PubMed
    121. Colomer A, Erill N, Vidal A, Calvo M, Roman R, Verdú M, Cordon-Cardo C, Puig X. A novel logistic model based on clinicopathological features predicts microsatellite instability in colorectal carcinomas. Diagn Mol Pathol. 2005 Dec; 14(4):213-23.
      View in: PubMed
    122. Brinck U, Cordon-Cardo C, Stachura J, Bortkiewicz P, Fischer G, Korabiowska M. Proposal of a new grading system for malignant fibrous histiocytomas. Anticancer Res. 2005 Nov-Dec; 25(6B):4293-8.
      View in: PubMed
    123. Korabiowska M, Hönig JF, Jawien J, Knapik J, Stachura J, Cordon-Cardo C, Fischer G. Relationship of nm23 expression to proliferation and prognosis in malignant melanomas of the oral cavity. In Vivo. 2005 Nov-Dec; 19(6):1093-6.
      View in: PubMed
    124. Capodieci P, Donovan M, Buchinsky H, Jeffers Y, Cordon-Cardo C, Gerald W, Edelson J, Shenoy SM, Singer RH. Gene expression profiling in single cells within tissue. Nat Methods. 2005 Sep; 2(9):663-5.
      View in: PubMed
    125. Hedvat CV, Teruya-Feldstein J, Puig P, Capodieci P, Dudas M, Pica N, Qin J, Cordon-Cardo C, Di Como CJ. Expression of p63 in diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol. 2005 Sep; 13(3):237-42.
      View in: PubMed
    126. Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, Cleveland JL, Tansey WP, Lowe SW. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature. 2005 Aug 11; 436(7052):807-11.
      View in: PubMed
    127. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005 Aug 4; 436(7051):725-30.
      View in: PubMed
    128. Ma L, Teruya-Feldstein J, Behrendt N, Chen Z, Noda T, Hino O, Cordon-Cardo C, Pandolfi PP. Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes Dev. 2005 Aug 1; 19(15):1779-86.
      View in: PubMed
    129. Korabiowska M, Ruschenburg I, Schulz H, Steinacker A, Bortkiewicz P, Sevenich M, Brinck U, Cordon-Cardo C, Fischer G. Cytokeratin expression correlates with aneuploidy in cytological specimens of melanoma metastases. Anticancer Res. 2005 Jul-Aug; 25(4):2789-92.
      View in: PubMed
    130. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM. A microRNA polycistron as a potential human oncogene. Nature. 2005 Jun 9; 435(7043):828-33.
      View in: PubMed
    131. Dunkel IJ, Abramson DH, Cordon-Cardo C, Chantada GL, de Davila MT, Fandino AC. P-glycoprotein expression in retinoblastoma. Br J Ophthalmol. 2005 Jun; 89(6):784.
      View in: PubMed
    132. Shah MA, Kortmansky J, Motwani M, Drobnjak M, Gonen M, Yi S, Weyerbacher A, Cordon-Cardo C, Lefkowitz R, Brenner B, O'Reilly E, Saltz L, Tong W, Kelsen DP, Schwartz GK. A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol. Clin Cancer Res. 2005 May 15; 11(10):3836-45.
      View in: PubMed
    133. Shah MA, Kemeny N, Hummer A, Drobnjak M, Motwani M, Cordon-Cardo C, Gonen M, Schwartz GK. Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes. Clin Cancer Res. 2005 May 1; 11(9):3296-302.
      View in: PubMed
    134. Gonzalez S, Perez-Perez MM, Hernando E, Serrano M, Cordon-Cardo C. p73beta-Mediated apoptosis requires p57kip2 induction and IEX-1 inhibition. Cancer Res. 2005 Mar 15; 65(6):2186-92.
      View in: PubMed
    135. Patel MI, Subbaramaiah K, Du B, Chang M, Yang P, Newman RA, Cordon-Cardo C, Thaler HT, Dannenberg AJ. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Clin Cancer Res. 2005 Mar 1; 11(5):1999-2007.
      View in: PubMed
    136. Morris MJ, Cordon-Cardo C, Kelly WK, Slovin SF, Siedlecki K, Regan KP, DiPaola RS, Rafi M, Rosen N, Scher HI. Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer. Appl Immunohistochem Mol Morphol. 2005 Mar; 13(1):6-13.
      View in: PubMed
    137. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, Teruya-Feldstein J, Pandolfi PP. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature. 2005 Jan 20; 433(7023):278-85.
      View in: PubMed
    138. Belbin TJ, Singh B, Smith RV, Socci ND, Wreesmann VB, Sanchez-Carbayo M, Masterson J, Patel S, Cordon-Cardo C, Prystowsky MB, Childs G. Molecular profiling of tumor progression in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2005 Jan; 131(1):10-8.
      View in: PubMed
    139. Niki M, Di Cristofano A, Zhao M, Honda H, Hirai H, Van Aelst L, Cordon-Cardo C, Pandolfi PP. Role of Dok-1 and Dok-2 in leukemia suppression. J Exp Med. 2004 Dec 20; 200(12):1689-95.
      View in: PubMed
    140. Erill N, Colomer A, Verdú M, Román R, Condom E, Hannaoui N, Banús JM, Cordon-Cardo C, Puig X. Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progression. Diagn Mol Pathol. 2004 Dec; 13(4):217-23.
      View in: PubMed
    141. Shuch B, Mikhail M, Satagopan J, Lee P, Yee H, Chang C, Cordon-Cardo C, Taneja SS, Osman I. Racial disparity of epidermal growth factor receptor expression in prostate cancer. J Clin Oncol. 2004 Dec 1; 22(23):4725-9.
      View in: PubMed
    142. Korabiowska M, Cordon-Cardo C, Jaenckel F, Stachura J, Fischer G, Brinck U. Application of in situ hybridization probes for MLH-1 and MSH-2 in tissue microarrays of paraffin-embedded malignant melanomas: correlation with immunohistochemistry and tumor stage. Hum Pathol. 2004 Dec; 35(12):1543-8.
      View in: PubMed
    143. Korabiowska M, Schlott T, Siems N, Müller A, Cordon-Cardo C, Fischer G, Brinck U. Analysis of adenomatous polyposis coli gene expression, APC locus-microsatellite instability and APC promoter methylation in the progression of melanocytic tumours. Mod Pathol. 2004 Dec; 17(12):1539-44.
      View in: PubMed
    144. Korabiowska M, Fischer G, Steinacker A, Stachura J, Cordon-Cardo C, Brinck U. Cytokeratin positivity in paraffin-embedded malignant melanomas: comparative study of KL1, A4 and Lu5 antibodies. Anticancer Res. 2004 Sep-Oct; 24(5B):3203-7.
      View in: PubMed
    145. Hernando E, Nahlé Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R, Lowe SW, Cordon-Cardo C. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature. 2004 Aug 12; 430(7001):797-802.
      View in: PubMed
    146. Afar DE, Bhaskar V, Ibsen E, Breinberg D, Henshall SM, Kench JG, Drobnjak M, Powers R, Wong M, Evangelista F, O'Hara C, Powers D, DuBridge RB, Caras I, Winter R, Anderson T, Solvason N, Stricker PD, Cordon-Cardo C, Scher HI, Grygiel JJ, Sutherland RL, Murray R, Ramakrishnan V, Law DA. Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. Mol Cancer Ther. 2004 Aug; 3(8):921-32.
      View in: PubMed
    147. Deng X, Hofmann ER, Villanueva A, Hobert O, Capodieci P, Veach DR, Yin X, Campodonico L, Glekas A, Cordon-Cardo C, Clarkson B, Bornmann WG, Fuks Z, Hengartner MO, Kolesnick R. Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation. Nat Genet. 2004 Aug; 36(8):906-12.
      View in: PubMed
    148. Korabiowska M, Cordon-Cardo C, Buschmann N, Stachura J, Fischer G, Brinck U. Comparison of DNA ploidy status and DNA ploidy-related parameters in malignant melanoma tissue microarrays and full sections. Hum Pathol. 2004 Jul; 35(7):887-91.
      View in: PubMed
    149. Chatterjee SJ, George B, Goebell PJ, Alavi-Tafreshi M, Shi SR, Fung YK, Jones PA, Cordon-Cardo C, Datar RH, Cote RJ. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer. J Pathol. 2004 Jul; 203(3):762-70.
      View in: PubMed
    150. Aguirre AJ, Brennan C, Bailey G, Sinha R, Feng B, Leo C, Zhang Y, Zhang J, Gans JD, Bardeesy N, Cauwels C, Cordon-Cardo C, Redston MS, DePinho RA, Chin L. High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci U S A. 2004 Jun 15; 101(24):9067-72.
      View in: PubMed
    151. Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C, Pandolfi PP. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med. 2004 May; 10(5):484-6.
      View in: PubMed
    152. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J, Lowe SW. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature. 2004 Mar 18; 428(6980):332-7.
      View in: PubMed
    153. Korabiowska M, König F, Verheggen R, Schlott T, Cordon-Cardo C, Romeike B, Brinck U. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases. Anticancer Res. 2004 Mar-Apr; 24(2B):981-6.
      View in: PubMed
    154. Kikuchi E, Menendez S, Ohori M, Cordon-Cardo C, Kasahara N, Bochner BH. Inhibition of orthotopic human bladder tumor growth by lentiviral gene transfer of endostatin. Clin Cancer Res. 2004 Mar 1; 10(5):1835-42.
      View in: PubMed
    155. Mao GE, Reuter VE, Cordon-Cardo C, Dalbagni G, Scher HI, DeKernion JB, Zhang ZF, Rao J. Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development. Cancer Epidemiol Biomarkers Prev. 2004 Mar; 13(3):383-90.
      View in: PubMed
    156. Cordon-Cardo C. p53 and RB: simple interesting correlates or tumor markers of critical predictive nature? J Clin Oncol. 2004 Mar 15; 22(6):975-7.
      View in: PubMed
    157. Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ, Verbel DA, Cordon-Cardo C, Pandolfi PP. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst. 2004 Feb 18; 96(4):269-79.
      View in: PubMed
    158. Korabiowska M, Bauer H, Quentin T, Stachura J, Cordon-Cardo C, Brinck U. Application of new in situ hybridization probes for Ku70 and Ku80 in tissue microarrays of paraffin-embedded malignant melanomas: correlation with immunohistochemical analysis. Hum Pathol. 2004 Feb; 35(2):210-6.
      View in: PubMed
    159. Mao GE, Morris G, Lu QY, Cao W, Reuter VE, Cordon-Cardo C, Dalbagni G, Scher HI, deKernion JB, Zhang ZF. Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detect Prev. 2004; 28(5):368-74.
      View in: PubMed
    160. Onel K, Cordon-Cardo C. MDM2 and prognosis. Mol Cancer Res. 2004 Jan; 2(1):1-8.
      View in: PubMed
    161. Richon VM, Zhou X, Secrist JP, Cordon-Cardo C, Kelly WK, Drobnjak M, Marks PA. Histone deacetylase inhibitors: assays to assess effectiveness in vitro and in vivo. Methods Enzymol. 2004; 376:199-205.
      View in: PubMed
    162. Sánchez-Carbayo M, Cordon-Cardo C. Applications of array technology: identification of molecular targets in bladder cancer. Br J Cancer. 2003 Dec 15; 89(12):2172-7.
      View in: PubMed
    163. Sanchez-Carbayo M, Saint F, Lozano JJ, Viale A, Cordon-Cardo C. Comparison of gene expression profiles in laser-microdissected, nonembedded, and OCT-embedded tumor samples by oligonucleotide microarray analysis. Clin Chem. 2003 Dec; 49(12):2096-100.
      View in: PubMed
    164. Gurrieri C, Nafa K, Merghoub T, Bernardi R, Capodieci P, Biondi A, Nimer S, Douer D, Cordon-Cardo C, Gallagher R, Pandolfi PP. Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia. Blood. 2004 Mar 15; 103(6):2358-62.
      View in: PubMed
    165. Puig P, Capodieci P, Drobnjak M, Verbel D, Prives C, Cordon-Cardo C, Di Como CJ. p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer. Clin Cancer Res. 2003 Nov 15; 9(15):5642-51.
      View in: PubMed
    166. Gonzalez S, Prives C, Cordon-Cardo C. p73alpha regulation by Chk1 in response to DNA damage. Mol Cell Biol. 2003 Nov; 23(22):8161-71.
      View in: PubMed
    167. Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, Xiao A, Khoo AS, Roy-Burman P, Greenberg NM, Van Dyke T, Cordon-Cardo C, Pandolfi PP. Pten dose dictates cancer progression in the prostate. PLoS Biol. 2003 Dec; 1(3):E59.
      View in: PubMed
    168. Fridman JS, Hernando E, Hemann MT, de Stanchina E, Cordon-Cardo C, Lowe SW. Tumor promotion by Mdm2 splice variants unable to bind p53. Cancer Res. 2003 Sep 15; 63(18):5703-6.
      View in: PubMed
    169. Xing HR, Cordon-Cardo C, Deng X, Tong W, Campodonico L, Fuks Z, Kolesnick R. Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer. Nat Med. 2003 Oct; 9(10):1266-8.
      View in: PubMed
    170. Sanchez-Carbayo M, Schwarz K, Charytonowicz E, Cordon-Cardo C, Mundel P. Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome. Oncogene. 2003 Aug 14; 22(34):5298-305.
      View in: PubMed
    171. Stojadinovic A, Brennan MF, Hoos A, Omeroglu A, Leung DH, Dudas ME, Nissan A, Cordon-Cardo C, Ghossein RA. Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis. Mod Pathol. 2003 Aug; 16(8):742-51.
      View in: PubMed
    172. Segal NH, Pavlidis P, Antonescu CR, Maki RG, Noble WS, DeSantis D, Woodruff JM, Lewis JJ, Brennan MF, Houghton AN, Cordon-Cardo C. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol. 2003 Aug; 163(2):691-700.
      View in: PubMed
    173. Sanchez-Carbayo M, Socci ND, Lozano JJ, Li W, Charytonowicz E, Belbin TJ, Prystowsky MB, Ortiz AR, Childs G, Cordon-Cardo C. Gene discovery in bladder cancer progression using cDNA microarrays. Am J Pathol. 2003 Aug; 163(2):505-16.
      View in: PubMed
    174. Drobnjak M, Melamed J, Taneja S, Melzer K, Wieczorek R, Levinson B, Zeleniuch-Jacquotte A, Polsky D, Ferrara J, Perez-Soler R, Cordon-Cardo C, Pagano M, Osman I. Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients. Clin Cancer Res. 2003 Jul; 9(7):2613-9.
      View in: PubMed
    175. Colomer A, Erill N, Verdú M, Roman R, Vidal A, Cordon-Cardo C, Puig X. Lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas. Appl Immunohistochem Mol Morphol. 2003 Jun; 11(2):130-7.
      View in: PubMed
    176. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 2003 Jun 1; 63(11):2872-80.
      View in: PubMed
    177. Polsky D, Cordon-Cardo C. Oncogenes in melanoma. Oncogene. 2003 May 19; 22(20):3087-91.
      View in: PubMed
    178. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003 May 16; 300(5622):1155-9.
      View in: PubMed
    179. Segal NH, Pavlidis P, Noble WS, Antonescu CR, Viale A, Wesley UV, Busam K, Gallardo H, DeSantis D, Brennan MF, Cordon-Cardo C, Wolchok JD, Houghton AN. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol. 2003 May 1; 21(9):1775-81.
      View in: PubMed
    180. Sanchez-Carbayo M, Belbin TJ, Scotlandi K, Prystowsky M, Baldini N, Childs G, Cordon-Cardo C. Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: regulation of cell adhesion, apoptosis, and tumor suppression-related genes. Lab Invest. 2003 Apr; 83(4):507-17.
      View in: PubMed
    181. Hemann MT, Fridman JS, Zilfou JT, Hernando E, Paddison PJ, Cordon-Cardo C, Hannon GJ, Lowe SW. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet. 2003 Mar; 33(3):396-400.
      View in: PubMed
    182. Blain SW, Scher HI, Cordon-Cardo C, Koff A. p27 as a target for cancer therapeutics. Cancer Cell. 2003 Feb; 3(2):111-5.
      View in: PubMed
    183. Sanchez-Carbayo M, Capodieci P, Cordon-Cardo C. Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. Am J Pathol. 2003 Feb; 162(2):609-17.
      View in: PubMed
    184. Gonen M, Hummer A, Zervoudakis A, Sullivan D, Fong Y, Banerjee D, Klimstra D, Cordon-Cardo C, Bertino J, Kemeny N. Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J Clin Oncol. 2003 Feb 1; 21(3):406-12.
      View in: PubMed
    185. Carneiro C, Jiao MS, Hu M, Shaffer D, Park M, Pandolfi PP, Cordon-Cardo C, Koff A. p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development. Oncogene. 2003 Jan 23; 22(3):361-9.
      View in: PubMed
    186. Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, Rao PH, Cordon-Cardo C, Pandolfi PP. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science. 2003 Jan 10; 299(5604):259-62.
      View in: PubMed
    187. Stojadinovic A, Hoos A, Nissan A, Dudas ME, Cordon-Cardo C, Shaha AR, Brennan MF, Singh B, Ghossein RA. Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol. 2003 Jan; 34(1):54-64.
      View in: PubMed
    188. Cheng J, Huang H, Pak J, Shapiro E, Sun TT, Cordon-Cardo C, Waldman FM, Wu XR. Allelic loss of p53 gene is associated with genesis and maintenance, but not invasion, of mouse carcinoma in situ of the bladder. Cancer Res. 2003 Jan 1; 63(1):179-85.
      View in: PubMed
    189. Polsky D, Melzer K, Hazan C, Panageas KS, Busam K, Drobnjak M, Kamino H, Spira JG, Kopf AW, Houghton A, Cordon-Cardo C, Osman I. HDM2 protein overexpression and prognosis in primary malignant melanoma. J Natl Cancer Inst. 2002 Dec 4; 94(23):1803-6.
      View in: PubMed
    190. Sanchez-Carbayo M, Socci ND, Charytonowicz E, Lu M, Prystowsky M, Childs G, Cordon-Cardo C. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res. 2002 Dec 1; 62(23):6973-80.
      View in: PubMed
    191. Juan G, Hernando E, Cordon-Cardo C. Separation of live cells in different phases of the cell cycle for gene expression analysis. Cytometry. 2002 Dec 1; 49(4):170-5.
      View in: PubMed
    192. Hoos A, Nissan A, Stojadinovic A, Shia J, Hedvat CV, Leung DH, Paty PB, Klimstra D, Cordon-Cardo C, Wong WD. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis. Clin Cancer Res. 2002 Dec; 8(12):3841-9.
      View in: PubMed
    193. Brinck U, Ruschenburg I, Di Como CJ, Buschmann N, Betke H, Stachura J, Cordon-Cardo C, Korabiowska M. Comparative study of p63 and p53 expression in tissue microarrays of malignant melanomas. Int J Mol Med. 2002 Dec; 10(6):707-11.
      View in: PubMed
    194. Lacorazza HD, Miyazaki Y, Di Cristofano A, Deblasio A, Hedvat C, Zhang J, Cordon-Cardo C, Mao S, Pandolfi PP, Nimer SD. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity. 2002 Oct; 17(4):437-49.
      View in: PubMed
    195. Urist MJ, Di Como CJ, Lu ML, Charytonowicz E, Verbel D, Crum CP, Ince TA, McKeon FD, Cordon-Cardo C. Loss of p63 expression is associated with tumor progression in bladder cancer. Am J Pathol. 2002 Oct; 161(4):1199-206.
      View in: PubMed
    196. Fox WD, Higgins B, Maiese KM, Drobnjak M, Cordon-Cardo C, Scher HI, Agus DB. Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer. Clin Cancer Res. 2002 Oct; 8(10):3226-31.
      View in: PubMed
    197. Korabiowska M, Tscherny M, Stachura J, Ruschenburg I, Cordon-Cardo C, Brinck U. Relationship between DNA mismatch repair genes expression, Ku-genes expression and ploidy-related parameters in the progression of pigmented lesions of the skin. In Vivo. 2002 Sep-Oct; 16(5):317-21.
      View in: PubMed
    198. Cho NH, Cordon-Cardo C, Li GC, Kim SH. Allotype imbalance or microsatellite mutation in low-grade soft tissue sarcomas of the extremities in adults. J Pathol. 2002 Sep; 198(1):21-9.
      View in: PubMed
    199. Hazan C, Melzer K, Panageas KS, Li E, Kamino H, Kopf A, Cordon-Cardo C, Osman I, Polsky D. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma. Cancer. 2002 Aug 1; 95(3):634-40.
      View in: PubMed
    200. Singh B, Stoffel A, Gogineni S, Poluri A, Pfister DG, Shaha AR, Pathak A, Bosl G, Cordon-Cardo C, Shah JP, Rao PH. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol. 2002 Aug; 161(2):365-71.
      View in: PubMed
    201. Spicker JS, Wikman F, Lu ML, Cordon-Cardo C, Workman C, ØRntoft TF, Brunak S, Knudsen S. Neural network predicts sequence of TP53 gene based on DNA chip. Bioinformatics. 2002 Aug; 18(8):1133-4.
      View in: PubMed
    202. Osman I, Sherman E, Singh B, Venkatraman E, Zelefsky M, Bosl G, Scher H, Shah J, Shaha A, Kraus D, Cordon-Cardo C, Pfister DG. Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent. J Clin Oncol. 2002 Jul 1; 20(13):2980-7.
      View in: PubMed
    203. Solit DB, Zheng FF, Drobnjak M, Münster PN, Higgins B, Verbel D, Heller G, Tong W, Cordon-Cardo C, Agus DB, Scher HI, Rosen N. 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts. Clin Cancer Res. 2002 May; 8(5):986-93.
      View in: PubMed
    204. Ladanyi M, Antonescu CR, Drobnjak M, Baren A, Lui MY, Golde DW, Cordon-Cardo C. The precrystalline cytoplasmic granules of alveolar soft part sarcoma contain monocarboxylate transporter 1 and CD147. Am J Pathol. 2002 Apr; 160(4):1215-21.
      View in: PubMed
    205. Korabiowska M, Tscherny M, Stachura J, Berger H, Cordon-Cardo C, Brinck U. Differential expression of DNA nonhomologous end-joining proteins Ku70 and Ku80 in melanoma progression. Mod Pathol. 2002 Apr; 15(4):426-33.
      View in: PubMed
    206. Morris MJ, Tong WP, Cordon-Cardo C, Drobnjak M, Kelly WK, Slovin SF, Terry KL, Siedlecki K, Swanson P, Rafi M, DiPaola RS, Rosen N, Scher HI. Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer. Clin Cancer Res. 2002 Mar; 8(3):679-83.
      View in: PubMed
    207. García-Castellano JM, Villanueva A, Healey JH, Sowers R, Cordon-Cardo C, Huvos A, Bertino JR, Meyers P, Gorlick R. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma. Clin Cancer Res. 2002 Mar; 8(3):782-7.
      View in: PubMed
    208. Stojadinovic A, Ghossein RA, Hoos A, Nissan A, Marshall D, Dudas M, Cordon-Cardo C, Jaques DP, Brennan MF. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol. 2002 Feb 15; 20(4):941-50.
      View in: PubMed
    209. Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002 Feb; 8(2):494-501.
      View in: PubMed
    210. Hoos A, Stojadinovic A, Singh B, Dudas ME, Leung DH, Shaha AR, Shah JP, Brennan MF, Cordon-Cardo C, Ghossein R. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays. Am J Pathol. 2002 Jan; 160(1):175-83.
      View in: PubMed
    211. Korabiowska M, Tscherny M, Grohmann U, Hönig JF, Bartkowski SB, Cordon-Cardo C, Brinck U. Decreased expression of Ku70/Ku80 proteins in malignant melanomas of the oral cavity. Anticancer Res. 2002 Jan-Feb; 22(1A):193-6.
      View in: PubMed
    212. Korabiowska M, Cordon-Cardo C, Betke H, Schlott T, Kotthaus M, Stachura J, Brinck U. GADD153 is an independent prognostic factor in melanoma: immunohistochemical and molecular genetic analysis. Histol Histopathol. 2002; 17(3):805-11.
      View in: PubMed
    213. Lu ML, Wikman F, Orntoft TF, Charytonowicz E, Rabbani F, Zhang Z, Dalbagni G, Pohar KS, Yu G, Cordon-Cardo C. Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods. Clin Cancer Res. 2002 Jan; 8(1):171-9.
      View in: PubMed
    214. Orlow I, Cordon-Cardo C. Evaluation of alterations in the tumor suppressor genes INK4A and INK4B in human bladder tumors. Methods Mol Biol. 2002; 179:43-59.
      View in: PubMed
    215. Hedvat CV, Jaffe ES, Qin J, Filippa DA, Cordon-Cardo C, Tosato G, Nimer SD, Teruya-Feldstein J. Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays. Mod Pathol. 2001 Dec; 14(12):1270-6.
      View in: PubMed
    216. Polsky D, Bastian BC, Hazan C, Melzer K, Pack J, Houghton A, Busam K, Cordon-Cardo C, Osman I. HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma. Cancer Res. 2001 Oct 15; 61(20):7642-6.
      View in: PubMed
    217. Hoos A, Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest. 2001 Oct; 81(10):1331-8.
      View in: PubMed
    218. Mora J, Cheung NK, Juan G, Illei P, Cheung I, Akram M, Chi S, Ladanyi M, Cordon-Cardo C, Gerald WL. Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res. 2001 Sep 15; 61(18):6892-8.
      View in: PubMed
    219. Osman I, Scher HI, Drobnjak M, Verbel D, Morris M, Agus D, Ross JS, Cordon-Cardo C. HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer. Clin Cancer Res. 2001 Sep; 7(9):2643-7.
      View in: PubMed
    220. Dalbagni G, Ren ZP, Herr H, Cordon-Cardo C, Reuter V. Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study. Clin Cancer Res. 2001 Sep; 7(9):2797-801.
      View in: PubMed
    221. Li WW, Takahashi N, Jhanwar S, Cordon-Cardo C, Elisseyeff Y, Jimeno J, Faircloth G, Bertino JR. Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent. Clin Cancer Res. 2001 Sep; 7(9):2908-11.
      View in: PubMed
    222. Hoos A, Stojadinovic A, Mastorides S, Urist MJ, Polsky D, Di Como CJ, Brennan MF, Cordon-Cardo C. High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomas. Cancer. 2001 Aug 15; 92(4):869-74.
      View in: PubMed
    223. Hernando E, Orlow I, Liberal V, Nohales G, Benezra R, Cordon-Cardo C. Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer. Int J Cancer. 2001 Jul 20; 95(4):223-7.
      View in: PubMed
    224. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C, Kolesnick R. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science. 2001 Jul 13; 293(5528):293-7.
      View in: PubMed
    225. Gaboli M, Kotsi PA, Gurrieri C, Cattoretti G, Ronchetti S, Cordon-Cardo C, Broxmeyer HE, Hromas R, Pandolfi PP. Mzf1 controls cell proliferation and tumorigenesis. Genes Dev. 2001 Jul 1; 15(13):1625-30.
      View in: PubMed
    226. Lu QY, Hung JC, Heber D, Go VL, Reuter VE, Cordon-Cardo C, Scher HI, Marshall JR, Zhang ZF. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2001 Jul; 10(7):749-56.
      View in: PubMed
    227. Roqué M, Reis ED, Cordon-Cardo C, Taubman MB, Fallon JT, Fuster V, Badimon JJ. Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model. Lab Invest. 2001 Jun; 81(6):895-903.
      View in: PubMed
    228. Orjuela M, Orlow I, Dudas M, Ponce-Castañeda MV, Ridaura C, Leal C, Salazar A, Abramson D, Gerald W, Cordon-Cardo C. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma. Hum Pathol. 2001 May; 32(5):537-44.
      View in: PubMed
    229. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, Leung DH, Kuo D, Brennan MF, Lewis JJ, Cordon-Cardo C. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol. 2001 Apr; 158(4):1245-51.
      View in: PubMed
    230. Hoos A, Lewis JJ, Antonescu CR, Dudas ME, Leon L, Woodruff JM, Brennan MF, Cordon-Cardo C. Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors. Cancer Res. 2001 Apr 1; 61(7):3171-5.
      View in: PubMed
    231. Esteller M, Cordon-Cardo C, Corn PG, Meltzer SJ, Pohar KS, Watkins DN, Capella G, Peinado MA, Matias-Guiu X, Prat J, Baylin SB, Herman JG. p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Cancer Res. 2001 Apr 1; 61(7):2816-21.
      View in: PubMed
    232. Butler LM, Webb Y, Agus DB, Higgins B, Tolentino TR, Kutko MC, LaQuaglia MP, Drobnjak M, Cordon-Cardo C, Scher HI, Breslow R, Richon VM, Rifkind RA, Marks PA. Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. Clin Cancer Res. 2001 Apr; 7(4):962-70.
      View in: PubMed
    233. Cordon-Cardo C. Applications of molecular diagnostics: solid tumor genetics can determine clinical treatment protocols. Mod Pathol. 2001 Mar; 14(3):254-7.
      View in: PubMed
    234. Rego EM, Wang ZG, Peruzzi D, He LZ, Cordon-Cardo C, Pandolfi PP. Role of promyelocytic leukemia (PML) protein in tumor suppression. J Exp Med. 2001 Feb 19; 193(4):521-29.
      View in: PubMed
    235. Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet. 2001 Feb; 27(2):222-4.
      View in: PubMed
    236. Juan G, Cordon-Cardo C. Intranuclear compartmentalization of cyclin E during the cell cycle: disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer. Cancer Res. 2001 Feb 1; 61(3):1220-6.
      View in: PubMed
    237. Kim SH, Cho NH, Tallini G, Dudas M, Lewis JJ, Cordon-Cardo C. Prognostic role of cyclin D1 in retroperitoneal sarcomas. Cancer. 2001 Jan 15; 91(2):428-34.
      View in: PubMed
    238. Roque M, Cordon-Cardo C, Fuster V, Reis ED, Drobnjak M, Badimon JJ. Modulation of apoptosis, proliferation, and p27 expression in a porcine coronary angioplasty model. Atherosclerosis. 2000 Dec; 153(2):315-22.
      View in: PubMed
    239. Reis ED, Roque M, Dansky H, Fallon JT, Badimon JJ, Cordon-Cardo C, Shiff SJ, Fisher EA. Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A. 2000 Nov 7; 97(23):12764-9.
      View in: PubMed
    240. McDevitt MR, Barendswaard E, Ma D, Lai L, Curcio MJ, Sgouros G, Ballangrud AM, Yang WH, Finn RD, Pellegrini V, Geerlings MW, Lee M, Brechbiel MW, Bander NH, Cordon-Cardo C, Scheinberg DA. An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer. Cancer Res. 2000 Nov 1; 60(21):6095-100.
      View in: PubMed
    241. Amler LC, Agus DB, LeDuc C, Sapinoso ML, Fox WD, Kern S, Lee D, Wang V, Leysens M, Higgins B, Martin J, Gerald W, Dracopoli N, Cordon-Cardo C, Scher HI, Hampton GM. Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res. 2000 Nov 1; 60(21):6134-41.
      View in: PubMed
    242. Reis ED, Roqué M, Cordon-Cardo C, Drobnjak M, Fuster V, Badimon JJ. Apoptosis, proliferation, and p27 expression during vessel wall healing: time course study in a mouse model of transluminal femoral artery injury. J Vasc Surg. 2000 Nov; 32(5):1022-9.
      View in: PubMed
    243. Wikman FP, Lu ML, Thykjaer T, Olesen SH, Andersen LD, Cordon-Cardo C, Orntoft TF. Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples. Clin Chem. 2000 Oct; 46(10):1555-61.
      View in: PubMed
    244. Orjuela M, Castaneda VP, Ridaura C, Lecona E, Leal C, Abramson DH, Orlow I, Gerald W, Cordon-Cardo C. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res. 2000 Oct; 6(10):4010-6.
      View in: PubMed
    245. Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res. 2000 Sep 15; 60(18):5165-70.
      View in: PubMed
    246. Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res. 2000 May; 6(5):1891-5.
      View in: PubMed
    247. McShane LM, Aamodt R, Cordon-Cardo C, Cote R, Faraggi D, Fradet Y, Grossman HB, Peng A, Taube SE, Waldman FM. Reproducibility of p53 immunohistochemistry in bladder tumors. National Cancer Institute, Bladder Tumor Marker Network. Clin Cancer Res. 2000 May; 6(5):1854-64.
      View in: PubMed
    248. Banerjee D, Gorlick R, Liefshitz A, Danenberg K, Danenberg PC, Danenberg PV, Klimstra D, Jhanwar S, Cordon-Cardo C, Fong Y, Kemeny N, Bertino JR. Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. Cancer Res. 2000 May 1; 60(9):2365-7.
      View in: PubMed
    249. Simak R, Capodieci P, Cohen DW, Fair WR, Scher H, Melamed J, Drobnjak M, Heston WD, Stix U, Steiner G, Cordon-Cardo C. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues. Histol Histopathol. 2000 Apr; 15(2):365-74.
      View in: PubMed
    250. Antonescu CR, Leung DH, Dudas M, Ladanyi M, Brennan M, Woodruff JM, Cordon-Cardo C. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications. Am J Pathol. 2000 Mar; 156(3):977-83.
      View in: PubMed
    251. Szijan I, Orlow I, Dalamon V, Vergani P, Danilowicz K, Mezzadri N, Cordon-Cardo C, Bruno OD. Alterations in the retinoblastoma pathway of cell cycle control in parathyroid tumors. Oncol Rep. 2000 Mar-Apr; 7(2):421-5.
      View in: PubMed
    252. Wang S, Guo M, Ouyang H, Li X, Cordon-Cardo C, Kurimasa A, Chen DJ, Fuks Z, Ling CC, Li GC. The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. Proc Natl Acad Sci U S A. 2000 Feb 15; 97(4):1584-8.
      View in: PubMed
    253. Cordon-Cardo C. Ronald A. DeLellis, M.D., recipient of the 1999 Fred W. Stewart Award. Am J Surg Pathol. 2000 Feb; 24(2):295.
      View in: PubMed
    254. Rabbani F, Cordon-Cardo C. Mutation of cell cycle regulators and their impact on superficial bladder cancer. Urol Clin North Am. 2000 Feb; 27(1):83-102, ix.
      View in: PubMed
    255. Cordon-Cardo C, Cote RJ, Sauter G. Genetic and molecular markers of urothelial premalignancy and malignancy. Scand J Urol Nephrol Suppl. 2000; (205):82-93.
      View in: PubMed
    256. Kourea HP, Orlow I, Scheithauer BW, Cordon-Cardo C, Woodruff JM. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Am J Pathol. 1999 Dec; 155(6):1855-60.
      View in: PubMed
    257. Kourea HP, Cordon-Cardo C, Dudas M, Leung D, Woodruff JM. Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas. Am J Pathol. 1999 Dec; 155(6):1885-91.
      View in: PubMed
    258. Cordon-Cardo C, Prives C. At the crossroads of inflammation and tumorigenesis. J Exp Med. 1999 Nov 15; 190(10):1367-70.
      View in: PubMed
    259. Agus DB, Cordon-Cardo C, Fox W, Drobnjak M, Koff A, Golde DW, Scher HI. Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence. J Natl Cancer Inst. 1999 Nov 3; 91(21):1869-76.
      View in: PubMed
    260. Brinck U, Korabiowska M, Buschmann N, Stachura J, Ruschenburg I, Cordon-Cardo C, Schauer A. Relevance of ploidy related parameters for prognosis in malignant fibrous histiocytomas. Anticancer Res. 1999 Nov-Dec; 19(6B):5211-6.
      View in: PubMed
    261. Agus DB, Scher HI, Higgins B, Fox WD, Heller G, Fazzari M, Cordon-Cardo C, Golde DW. Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models. Cancer Res. 1999 Oct 1; 59(19):4761-4.
      View in: PubMed
    262. Di Cristofano A, Kotsi P, Peng YF, Cordon-Cardo C, Elkon KB, Pandolfi PP. Impaired Fas response and autoimmunity in Pten+/- mice. Science. 1999 Sep 24; 285(5436):2122-5.
      View in: PubMed
    263. Cordon-Cardo C. At the crossroad of tumorigenesis: drivers and hitchhikers. Hum Pathol. 1999 Sep; 30(9):1001-3.
      View in: PubMed
    264. Osman I, Drobnjak M, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C. Inactivation of the p53 pathway in prostate cancer: impact on tumor progression. Clin Cancer Res. 1999 Aug; 5(8):2082-8.
      View in: PubMed
    265. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner JW, Cordon-Cardo C, Yancopoulos GD, DePinho RA. Essential role for oncogenic Ras in tumour maintenance. Nature. 1999 Jul 29; 400(6743):468-72.
      View in: PubMed
    266. Orlow I, LaRue H, Osman I, Lacombe L, Moore L, Rabbani F, Meyer F, Fradet Y, Cordon-Cardo C. Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence. Am J Pathol. 1999 Jul; 155(1):105-13.
      View in: PubMed
    267. Ghossein RA, Osman I, Bhattacharya S, Ferrara J, Fazzari M, Cordon-Cardo C, Scher HI. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction. Diagn Mol Pathol. 1999 Jun; 8(2):59-65.
      View in: PubMed
    268. Park MS, Rosai J, Nguyen HT, Capodieci P, Cordon-Cardo C, Koff A. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proc Natl Acad Sci U S A. 1999 May 25; 96(11):6382-7.
      View in: PubMed
    269. Rabbani F, Richon VM, Orlow I, Lu ML, Drobnjak M, Dudas M, Charytonowicz E, Dalbagni G, Cordon-Cardo C. Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J Natl Cancer Inst. 1999 May 19; 91(10):874-81.
      View in: PubMed
    270. Lee CT, Capodieci P, Osman I, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer. Clin Cancer Res. 1999 May; 5(5):977-83.
      View in: PubMed
    271. Kurimasa A, Ouyang H, Dong LJ, Wang S, Li X, Cordon-Cardo C, Chen DJ, Li GC. Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. Proc Natl Acad Sci U S A. 1999 Feb 16; 96(4):1403-8.
      View in: PubMed
    272. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A. 1999 Feb 16; 96(4):1563-8.
      View in: PubMed
    273. Orlow I, Drobnjak M, Zhang ZF, Lewis J, Woodruff JM, Brennan MF, Cordon-Cardo C. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival. J Natl Cancer Inst. 1999 Jan 6; 91(1):73-9.
      View in: PubMed
    274. Herr HW, Bajorin DF, Scher HI, Cordon-Cardo C, Reuter VE. Can p53 help select patients with invasive bladder cancer for bladder preservation? J Urol. 1999 Jan; 161(1):20-2; discussion 22-3.
      View in: PubMed
    275. Zhang S, Zhang HS, Cordon-Cardo C, Ragupathi G, Livingston PO. Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens. Clin Cancer Res. 1998 Nov; 4(11):2669-76.
      View in: PubMed
    276. Kim SH, Lewis JJ, Brennan MF, Woodruff JM, Dudas M, Cordon-Cardo C. Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas. Clin Cancer Res. 1998 Oct; 4(10):2377-82.
      View in: PubMed
    277. Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J, Scher HI. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst. 1998 Sep 2; 90(17):1284-91.
      View in: PubMed
    278. Heslin MJ, Cordon-Cardo C, Lewis JJ, Woodruff JM, Brennan MF. Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma. Cancer. 1998 Aug 1; 83(3):490-7.
      View in: PubMed
    279. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. Pten is essential for embryonic development and tumour suppression. Nat Genet. 1998 Aug; 19(4):348-55.
      View in: PubMed
    280. Agus DB, Golde DW, Sgouros G, Ballangrud A, Cordon-Cardo C, Scher HI. Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal. Cancer Res. 1998 Jul 15; 58(14):3009-14.
      View in: PubMed
    281. Li GC, Ouyang H, Li X, Nagasawa H, Little JB, Chen DJ, Ling CC, Fuks Z, Cordon-Cardo C. Ku70: a candidate tumor suppressor gene for murine T cell lymphoma. Mol Cell. 1998 Jul; 2(1):1-8.
      View in: PubMed
    282. Pasche B, Luo Y, Rao PH, Nimer SD, Dmitrovsky E, Caron P, Luzzatto L, Offit K, Cordon-Cardo C, Renault B, Satagopan JM, Murty VV, Massagué J. Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res. 1998 Jul 1; 58(13):2727-32.
      View in: PubMed
    283. Cote RJ, Shi Y, Groshen S, Feng AC, Cordon-Cardo C, Skinner D, Lieskovosky G. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. J Natl Cancer Inst. 1998 Jun 17; 90(12):916-20.
      View in: PubMed
    284. Schreiber-Agus N, Meng Y, Hoang T, Hou H, Chen K, Greenberg R, Cordon-Cardo C, Lee HW, DePinho RA. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature. 1998 Jun 4; 393(6684):483-7.
      View in: PubMed
    285. Lianes P, Charytonowicz E, Cordon-Cardo C, Fradet Y, Grossman HB, Hemstreet GP, Waldman FM, Chew K, Wheeless LL, Faraggi D. Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network. Clin Cancer Res. 1998 May; 4(5):1267-71.
      View in: PubMed
    286. Pomerantz J, Schreiber-Agus N, Liégeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell. 1998 Mar 20; 92(6):713-23.
      View in: PubMed
    287. Wu RL, Osman I, Wu XR, Lu ML, Zhang ZF, Liang FX, Hamza R, Scher H, Cordon-Cardo C, Sun TT. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Res. 1998 Mar 15; 58(6):1291-7.
      View in: PubMed
    288. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F, Pandolfi PP. Role of PML in cell growth and the retinoic acid pathway. Science. 1998 Mar 6; 279(5356):1547-51.
      View in: PubMed
    289. Rivas CI, Vera JC, Delgado-López F, Heaney ML, Guaiquil VH, Zhang RH, Scher HI, Concha II, Nualart F, Cordon-Cardo C, Golde DW. Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer. Blood. 1998 Feb 1; 91(3):1037-43.
      View in: PubMed
    290. Brinck U, Cordon-Cardo C, Korabiowska M, Kellner S, Trybus-Galuszka H, Stachura J, Parwaresch MR, Schauer A. Prognostic relevance of histologic grading, the cell cycle-associated antigen Ki-S1 and cell cycle regulators in malignant fibrous histiocytomas: a multivariate analysis. Verh Dtsch Ges Pathol. 1998; 82:232-8.
      View in: PubMed
    291. Cordon-Cardo C. Cell cycle regulators as prognostic factors for bladder cancer. Eur Urol. 1998; 33 Suppl 4:11-2.
      View in: PubMed
    292. Cordon-Cardo C. Molecular alterations in bladder cancer. Cancer Surv. 1998; 32:115-31.
      View in: PubMed
    293. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, Edwards CK, Schuchman EH, Fuks Z, Kolesnick R. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med. 1997 Dec 1; 186(11):1831-41.
      View in: PubMed
    294. Osman I, Scher H, Zhang ZF, Soos TJ, Hamza R, Eissa S, Khaled H, Koff A, Cordon-Cardo C. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer. Clin Cancer Res. 1997 Dec; 3(12 Pt 1):2247-51.
      View in: PubMed
    295. Chin L, Pomerantz J, Polsky D, Jacobson M, Cohen C, Cordon-Cardo C, Horner JW, DePinho RA. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 1997 Nov 1; 11(21):2822-34.
      View in: PubMed
    296. Zhang S, Cordon-Cardo C, Zhang HS, Reuter VE, Adluri S, Hamilton WB, Lloyd KO, Livingston PO. Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides. Int J Cancer. 1997 Sep 26; 73(1):42-9.
      View in: PubMed
    297. Zhang S, Zhang HS, Cordon-Cardo C, Reuter VE, Singhal AK, Lloyd KO, Livingston PO. Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens. Int J Cancer. 1997 Sep 26; 73(1):50-6.
      View in: PubMed
    298. Ouyang H, Nussenzweig A, Kurimasa A, Soares VC, Li X, Cordon-Cardo C, Li Wh, Cheong N, Nussenzweig M, Iliakis G, Chen DJ, Li GC. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination In vivo. J Exp Med. 1997 Sep 15; 186(6):921-9.
      View in: PubMed
    299. Dalbagni G, Han W, Zhang ZF, Cordon-Cardo C, Saigo P, Fair WR, Herr H, Kim N, Moore MA. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res. 1997 Sep; 3(9):1593-8.
      View in: PubMed
    300. Cordon-Cardo C, Sheinfeld J, Dalbagni G. Genetic studies and molecular markers of bladder cancer. Semin Surg Oncol. 1997 Sep-Oct; 13(5):319-27.
      View in: PubMed
    301. Richon VM, Russo P, Venta-Perez G, Cordon-Cardo C, Rifkind RA, Marks PA. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells. Cancer Res. 1997 Jul 1; 57(13):2789-98.
      View in: PubMed
    302. Howe JR, Klimstra DS, Cordon-Cardo C. DNA extraction from paraffin-embedded tissues using a salting-out procedure: a reliable method for PCR amplification of archival material. Histol Histopathol. 1997 Jul; 12(3):595-601.
      View in: PubMed
    303. Osman I, Scher H, Dalbagni G, Reuter V, Zhang ZF, Cordon-Cardo C. Chromosome 16 in primary prostate cancer: a microsatellite analysis. Int J Cancer. 1997 May 16; 71(4):580-4.
      View in: PubMed
    304. Zhang ZF, Shu XM, Cordon-Cardo C, Orlow I, Lu ML, Millon TV, Cao PQ, Connolly-Jenks C, Dalbagni G, Lianes P, Lacombe L, Reuter VE, Scher H. Cigarette smoking and chromosome 9 alterations in bladder cancer. Cancer Epidemiol Biomarkers Prev. 1997 May; 6(5):321-6.
      View in: PubMed
    305. Cordon-Cardo C, Reuter VE. Alterations of tumor suppressor genes in bladder cancer. Semin Diagn Pathol. 1997 May; 14(2):123-32.
      View in: PubMed
    306. Cordon-Cardo C, Zhang ZF, Dalbagni G, Drobnjak M, Charytonowicz E, Hu SX, Xu HJ, Reuter VE, Benedict WF. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res. 1997 Apr 1; 57(7):1217-21.
      View in: PubMed
    307. Osman I, Scher HI, Zhang ZF, Pellicer I, Hamza R, Eissa S, Khaled H, Cordon-Cardo C. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer. Clin Cancer Res. 1997 Apr; 3(4):531-6.
      View in: PubMed
    308. Manetto V, Lorenzini R, Cordon-Cardo C, Krajewski S, Rosai J, Reed JC, Eusebi V. Bcl-2 and Bax expression in thyroid tumours. An immunohistochemical and western blot analysis. Virchows Arch. 1997 Feb; 430(2):125-30.
      View in: PubMed
    309. Cordon-Cardo C. The 1996 Fred W. Stewart Award. Lance A. Liotta, M.D., Ph.D., Recipient of the 1996 Fred W. Stewart Award. Am J Surg Pathol. 1997 Feb; 21(2):249.
      View in: PubMed
    310. Zhang ZF, Cordon-Cardo C, Rothman N, Freedman AN, Taylor JA. Methodological issues in the use of tumour markers in cancer epidemiology. IARC Sci Publ. 1997; (142):201-13.
      View in: PubMed
    311. Cordon-Cardo C, Sheinfeld J. Molecular and immunopathology studies of oncogenes and tumor-suppressor genes in bladder cancer. World J Urol. 1997; 15(2):112-9.
      View in: PubMed
    312. Howe JR, Klimstra DS, Cordon-Cardo C, Paty PB, Park PY, Brennan MF. K-ras mutation in adenomas and carcinomas of the ampulla of vater. Clin Cancer Res. 1997 Jan; 3(1):129-33.
      View in: PubMed
    313. Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997 Jan; 3(1):81-5.
      View in: PubMed
    314. Li WW, Cordon-Cardo C, Chen Q, Jhanwar SC, Bertino JR. Establishment, characterization and drug sensitivity of four new human soft tissue sarcoma cell lines. Int J Cancer. 1996 Nov 15; 68(4):514-9.
      View in: PubMed
    315. Lacombe L, Dalbagni G, Zhang ZF, Cordon-Cardo C, Fair WR, Herr HW, Reuter VE. Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome. J Clin Oncol. 1996 Oct; 14(10):2646-52.
      View in: PubMed
    316. Li M, Cordon-Cardo C, Gerald WL, Rosai J. Desmoid fibromatosis is a clonal process. Hum Pathol. 1996 Sep; 27(9):939-43.
      View in: PubMed
    317. Santana P, Peña LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z, Kolesnick R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 1996 Jul 26; 86(2):189-99.
      View in: PubMed
    318. Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HS, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Weinstein R. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res. 1996 Jul 1; 56(13):3010-20.
      View in: PubMed
    319. Li M, Zhang ZF, Reuter VE, Cordon-Cardo C. Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am J Pathol. 1996 Jul; 149(1):229-35.
      View in: PubMed
    320. Presti JC, Moch H, Reuter VE, Cordon-Cardo C, Waldman FM. Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis. J Urol. 1996 Jul; 156(1):281-5.
      View in: PubMed
    321. Lacombe L, Orlow I, Reuter VE, Fair WR, Dalbagni G, Zhang ZF, Cordon-Cardo C. Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer. Int J Cancer. 1996 Apr 22; 69(2):110-3.
      View in: PubMed
    322. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 1996 Apr 5; 85(1):27-37.
      View in: PubMed
    323. Presti JC, Reuter VE, Cordon-Cardo C, Motzer RJ, Albino AP, Jhanwar SC, Nanus DM. Expression of the retinoblastoma gene product in renal tumors. Anticancer Res. 1996 Mar-Apr; 16(2):549-56.
      View in: PubMed
    324. Lacombe L, Orlow I, Silver D, Gerald WL, Fair WR, Reuter VE, Cordon-Cardo C. Analysis of p21WAF1/CIP1 in primary bladder tumors. Oncol Res. 1996; 8(10-11):409-14.
      View in: PubMed
    325. Orlow I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Dalbagni G, Reuter VE, Zhang ZF, Beach D, Cordon-Cardo C. Deletion of the p16 and p15 genes in human bladder tumors. J Natl Cancer Inst. 1995 Oct 18; 87(20):1524-9.
      View in: PubMed
    326. Karpeh MS, Brennan MF, Cance WG, Woodruff JM, Pollack D, Casper ES, Dudas ME, Latres E, Drobnjak M, Cordon-Cardo C. Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas. Br J Cancer. 1995 Oct; 72(4):986-91.
      View in: PubMed
    327. Zhang ZF, Karpeh MS, Lauwers GY, Marrero AM, Pollack D, Cordon-Cardo C, Begg CB. A case-series study of p53 nuclear overexpression in early-stage stomach cancer. Ann N Y Acad Sci. 1995 Sep 30; 768:269-71.
      View in: PubMed
    328. Cordon-Cardo C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol. 1995 Sep; 147(3):545-60.
      View in: PubMed
    329. Chin L, Schreiber-Agus N, Pellicer I, Chen K, Lee HW, Dudast M, Cordon-Cardo C, DePinho RA. Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc Natl Acad Sci U S A. 1995 Aug 29; 92(18):8488-92.
      View in: PubMed
    330. Motzer RJ, Lyn P, Fischer P, Lianes P, Ngo RL, Cordon-Cardo C, O'Brien JP. Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma. J Clin Oncol. 1995 Aug; 13(8):1958-65.
      View in: PubMed
    331. Rosenfeld MR, Meneses P, Dalmau J, Drobnjak M, Cordon-Cardo C, Kaplitt MG. Gene transfer of wild-type p53 results in restoration of tumor-suppressor function in a medulloblastoma cell line. Neurology. 1995 Aug; 45(8):1533-9.
      View in: PubMed
    332. Sarkis AS, Bajorin DF, Reuter VE, Herr HW, Netto G, Zhang ZF, Schultz PK, Cordon-Cardo C, Scher HI. Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC. J Clin Oncol. 1995 Jun; 13(6):1384-90.
      View in: PubMed
    333. Arbit E, Cheung NK, Yeh SD, Daghighian F, Zhang JJ, Cordon-Cardo C, Pentlow K, Canete A, Finn R, Larson SM. Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors. Eur J Nucl Med. 1995 May; 22(5):419-26.
      View in: PubMed
    334. Fuks Z, Alfieri A, Haimovitz-Friedman A, Seddon A, Cordon-Cardo C. Intravenous basic fibroblast growth factor protects the lung but not mediastinal organs against radiation-induced apoptosis in vivo. Cancer J Sci Am. 1995 May-Jun; 1(1):62-72.
      View in: PubMed
    335. Scher HI, Sarkis A, Reuter V, Cohen D, Netto G, Petrylak D, Lianes P, Fuks Z, Mendelsohn J, Cordon-Cardo C. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. Clin Cancer Res. 1995 May; 1(5):545-50.
      View in: PubMed
    336. Zhang ZF, Zeng ZS, Sarkis AS, Klimstra DS, Charytonowicz E, Pollack D, Vena J, Guillem J, Marshall JR, Cordon-Cardo C, et al. Family history of cancer, body weight, and p53 nuclear overexpression in Duke's C colorectal cancer. Br J Cancer. 1995 Apr; 71(4):888-93.
      View in: PubMed
    337. Dalbagni G, Cordon-Cardo C, Reuter V, Fair WR. Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practice. Surg Oncol Clin N Am. 1995 Apr; 4(2):231-40.
      View in: PubMed
    338. Oliva MR, Saez GT, Latres E, Cordon-Cardo C. A new polymorphic site in intron 2 of TP53 characterizes LOH in human tumors by PCR-SSCP. Diagn Mol Pathol. 1995 Mar; 4(1):54-8.
      View in: PubMed
    339. Zhang ZF, Karpeh MS, Lauwers GY, Marrero AM, Pollack D, Cordon-Cardo C, Begg C. Risk factors and p53 nuclear overexpression in early stage intestinal-type adenocarcinoma of the stomach. Cancer Detect Prev. 1995; 19(2):156-64.
      View in: PubMed
    340. Cohen DW, Simak R, Fair WR, Melamed J, Scher HI, Cordon-Cardo C. Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues. J Urol. 1994 Dec; 152(6 Pt 1):2120-4.
      View in: PubMed
    341. Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C. Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem. 1994 Nov; 42(11):1417-25.
      View in: PubMed
    342. Petrylak DP, Scher HI, Reuter V, O'Brien JP, Cordon-Cardo C. P-glycoprotein expression in primary and metastatic transitional cell carcinoma of the bladder. Ann Oncol. 1994 Nov; 5(9):835-40.
      View in: PubMed
    343. Zeng ZS, Sarkis AS, Zhang ZF, Klimstra DS, Charytonowicz E, Guillem JG, Cordon-Cardo C, Cohen AM. p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients. J Clin Oncol. 1994 Oct; 12(10):2043-50.
      View in: PubMed
    344. Armas OA, Aprikian AG, Melamed J, Cordon-Cardo C, Cohen DW, Erlandson R, Fair WR, Reuter VE. Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma. Am J Surg Pathol. 1994 Oct; 18(10):979-91.
      View in: PubMed
    345. Lianes P, Orlow I, Zhang ZF, Oliva MR, Sarkis AS, Reuter VE, Cordon-Cardo C. Altered patterns of MDM2 and TP53 expression in human bladder cancer. J Natl Cancer Inst. 1994 Sep 7; 86(17):1325-30.
      View in: PubMed
    346. Latres E, Drobnjak M, Pollack D, Oliva MR, Ramos M, Karpeh M, Woodruff JM, Cordon-Cardo C. Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas. Am J Pathol. 1994 Aug; 145(2):345-55.
      View in: PubMed
    347. Sarkis AS, Dalbagni G, Cordon-Cardo C, Melamed J, Zhang ZF, Sheinfeld J, Fair WR, Herr HW, Reuter VE. Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J Urol. 1994 Aug; 152(2 Pt 1):388-92.
      View in: PubMed
    348. Kamb A, Liu Q, Harshman K, Tavtigian S, Cordon-Cardo C, Skolnick MH. Response. Science. 1994 Jul 15; 265(5170):416-7.
      View in: PubMed
    349. Sagerman PM, Saigo PE, Sheinfeld J, Charitonowics E, Cordon-Cardo C. Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigens. Acta Cytol. 1994 Jul-Aug; 38(4):517-23.
      View in: PubMed
    350. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, Cordon-Cardo C. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res. 1994 Jun 1; 54(11):2848-51.
      View in: PubMed
    351. Fuks Z, Persaud RS, Alfieri A, McLoughlin M, Ehleiter D, Schwartz JL, Seddon AP, Cordon-Cardo C, Haimovitz-Friedman A. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 1994 May 15; 54(10):2582-90.
      View in: PubMed
    352. Aprikian AG, Sarkis AS, Fair WR, Zhang ZF, Fuks Z, Cordon-Cardo C. Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. J Urol. 1994 May; 151(5):1276-80.
      View in: PubMed
    353. Drobnjak M, Latres E, Pollack D, Karpeh M, Dudas M, Woodruff JM, Brennan MF, Cordon-Cardo C. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J Natl Cancer Inst. 1994 Apr 6; 86(7):549-54.
      View in: PubMed
    354. Aprikian AG, Cordon-Cardo C, Fair WR, Zhang ZF, Bazinet M, Hamdy SM, Reuter VE. Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. J Urol. 1994 Apr; 151(4):914-9.
      View in: PubMed
    355. Tallini G, Parham DM, Dias P, Cordon-Cardo C, Houghton PJ, Rosai J. Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation. Am J Pathol. 1994 Apr; 144(4):693-701.
      View in: PubMed
    356. Bannerji R, Arroyo CD, Cordon-Cardo C, Gilboa E. The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity. J Immunol. 1994 Mar 1; 152(5):2324-32.
      View in: PubMed
    357. Cordon-Cardo C, Richon VM. Expression of the retinoblastoma protein is regulated in normal human tissues. Am J Pathol. 1994 Mar; 144(3):500-10.
      View in: PubMed
    358. Bosl GJ, Fair WR, Herr HW, Bajorin DF, Dalbagni G, Sarkis AS, Reuter VE, Cordon-Cardo C, Sheinfeld J, Scher HI. Bladder cancer: advances in biology and treatment. Crit Rev Oncol Hematol. 1994 Feb; 16(1):33-70.
      View in: PubMed
    359. Cordon-Cardo C, Dalbagni G, Saez GT, Oliva MR, Zhang ZF, Rosai J, Reuter VE, Pellicer A. p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int J Cancer. 1994 Feb 1; 56(3):347-53.
      View in: PubMed
    360. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res. 1994 Feb 1; 54(3):794-9.
      View in: PubMed
    361. Drudis T, Arroyo C, Van Hoeven K, Cordon-Cardo C, Rosen PP. The pathology of low-grade adenosquamous carcinoma of the breast. An immunohistochemical study. Pathol Annu. 1994; 29 ( Pt 2):181-97.
      View in: PubMed
    362. Cordon-Cardo C, Dalbagni G, Sarkis AS, Reuter VE. Genetic alterations associated with bladder cancer. Important Adv Oncol. 1994; 71-83.
      View in: PubMed
    363. Kostakoglu L, Divgi CR, Hilton S, Cordon-Cardo C, Scott AM, Kalaigian H, Finn RD, Schlom J, Larson SM. Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49. Cancer Invest. 1994; 12(6):551-8.
      View in: PubMed
    364. Casper ES, Cordon-Cardo C, Houghton AN, Steffens TA, McCormack P, Magill GB, Hajdu SI, Brennan MF. Biological study of R24 mouse monoclonal antibody in patients undergoing thoracotomy for pulmonary metastases from soft tissue sarcoma. Cancer Invest. 1994; 12(1):20-5.
      View in: PubMed
    365. Zhang ZF, Sarkis AS, Cordon-Cardo C, Dalbagni G, Melamed J, Aprikian A, Pollack D, Sheinfeld J, Herr HW, Fair WR, et al. Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer. Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb; 3(1):19-24.
      View in: PubMed
    366. Presti JC, Reuter VE, Cordon-Cardo C, Mazumdar M, Fair WR, Jhanwar SC. Allelic deletions in renal tumors: histopathological correlations. Cancer Res. 1993 Dec 1; 53(23):5780-3.
      View in: PubMed
    367. Nanus DM, Schmitz-Dräger BJ, Motzer RJ, Lee AC, Vlamis V, Cordon-Cardo C, Albino AP, Reuter VE. Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J Natl Cancer Inst. 1993 Oct 6; 85(19):1597-9.
      View in: PubMed
    368. Dalbagni G, Presti J, Reuter V, Fair WR, Cordon-Cardo C. Genetic alterations in bladder cancer. Lancet. 1993 Aug 21; 342(8869):469-71.
      View in: PubMed
    369. Fradet Y, Cordon-Cardo C. Critical appraisal of tumor markers in bladder cancer. Semin Urol. 1993 Aug; 11(3):145-53.
      View in: PubMed
    370. Aprikian AG, Sarkis AS, Reuter VE, Cordon-Cardo C, Sheinfeld J. Biological markers of prognosis in transitional cell carcinoma of the bladder: current concepts. Semin Urol. 1993 Aug; 11(3):137-44.
      View in: PubMed
    371. Reissmann PT, Koga H, Takahashi R, Figlin RA, Holmes EC, Piantadosi S, Cordon-Cardo C, Slamon DJ. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Oncogene. 1993 Jul; 8(7):1913-9.
      View in: PubMed
    372. Aprikian AG, Cordon-Cardo C, Fair WR, Reuter VE. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer. 1993 Jun 15; 71(12):3952-65.
      View in: PubMed
    373. Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J, Dmitrovsky E. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res. 1993 May 15; 53(10 Suppl):2379-85.
      View in: PubMed
    374. Jähne J, Urmacher C, Cordon-Cardo C, Meyer HJ, Pichlmayr R. [DNA analysis in stomach cancer--correlation of aneuploidy with tumor site]. Chirurg. 1993 Apr; 64(4):275-8.
      View in: PubMed
    375. Dalbagni G, Presti JC, Reuter VE, Zhang ZF, Sarkis AS, Fair WR, Cordon-Cardo C. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diagn Mol Pathol. 1993 Mar; 2(1):4-13.
      View in: PubMed
    376. Sarkis AS, Dalbagni G, Cordon-Cardo C, Zhang ZF, Sheinfeld J, Fair WR, Herr HW, Reuter VE. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst. 1993 Jan 6; 85(1):53-9.
      View in: PubMed
    377. Bajorin DF, Chapman PB, Wong GY, Cody BV, Cordon-Cardo C, Dantes L, Templeton MA, Scheinberg D, Oettgen HF, Houghton AN. Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma. Melanoma Res. 1992 Dec; 2(5-6):355-62.
      View in: PubMed
    378. Dalmau J, Furneaux HM, Cordon-Cardo C, Posner JB. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol. 1992 Oct; 141(4):881-6.
      View in: PubMed
    379. Garberoglio C, Dudas M, Casper ES, Bertino J, Cordon-Cardo C. Expression of P-glycoprotein in normal muscle cells and myogenic tumors. Arch Pathol Lab Med. 1992 Oct; 116(10):1055-61.
      View in: PubMed
    380. Henson JW, Cordon-Cardo C, Posner JB. P-glycoprotein expression in brain tumors. J Neurooncol. 1992 Sep; 14(1):37-43.
      View in: PubMed
    381. Dalbagni G, Reuter VE, Sheinfeld J, Fradet Y, Fair WR, Cordon-Cardo C. Cell surface differentiation antigens of normal urothelium and bladder tumors. Semin Surg Oncol. 1992 Sep-Oct; 8(5):293-9.
      View in: PubMed
    382. Sheinfeld J, Reuter VE, Fair WR, Cordon-Cardo C. Expression of blood group antigens in bladder cancer: current concepts. Semin Surg Oncol. 1992 Sep-Oct; 8(5):308-15.
      View in: PubMed
    383. Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst. 1992 Aug 19; 84(16):1251-6.
      View in: PubMed
    384. Chang HR, Cordon-Cardo C, Houghton AN, Cheung NK, Brennan MF. Expression of disialogangliosides GD2 and GD3 on human soft tissue sarcomas. Cancer. 1992 Aug 1; 70(3):633-8.
      View in: PubMed
    385. Tiwari RK, Borgen PI, Wong GY, Cordon-Cardo C, Osborne MP. HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis. Anticancer Res. 1992 Mar-Apr; 12(2):419-25.
      View in: PubMed
    386. Cordon-Cardo C, Wartinger DD, Melamed MR, Fair W, Fradet Y. Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors. Am J Pathol. 1992 Feb; 140(2):375-85.
      View in: PubMed
    387. Sheinfeld J, Reuter VE, Sarkis AS, Cordon-Cardo C. Blood group antigens in normal and neoplastic urothelium. J Cell Biochem Suppl. 1992; 16I:50-5.
      View in: PubMed
    388. Jaehne J, Urmacher C, Thaler HT, Friedlander-Klar H, Cordon-Cardo C, Meyer HJ. Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma. J Cancer Res Clin Oncol. 1992; 118(6):474-9.
      View in: PubMed
    389. Cordon-Cardo C, Fuks Z, Drobnjak M, Moreno C, Eisenbach L, Feldman M. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res. 1991 Dec 1; 51(23 Pt 1):6372-80.
      View in: PubMed
    390. Wood DP, Wartinger DD, Reuter V, Cordon-Cardo C, Fair WR, Chaganti RS. DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder. J Urol. 1991 Nov; 146(5):1398-401.
      View in: PubMed
    391. Presti JC, Reuter VE, Galan T, Fair WR, Cordon-Cardo C. Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res. 1991 Oct 1; 51(19):5405-9.
      View in: PubMed
    392. O'Brien JP, Cordon-Cardo C. On the origins of clinical drug resistance. Semin Cancer Biol. 1991 Aug; 2(4):227-33.
      View in: PubMed
    393. Strohmeyer T, Reissmann P, Cordon-Cardo C, Hartmann M, Ackermann R, Slamon D. Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Natl Acad Sci U S A. 1991 Aug 1; 88(15):6662-6.
      View in: PubMed
    394. Klein R, Nanduri V, Jing SA, Lamballe F, Tapley P, Bryant S, Cordon-Cardo C, Jones KR, Reichardt LF, Barbacid M. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell. 1991 Jul 26; 66(2):395-403.
      View in: PubMed
    395. Cordon-Cardo C, Tapley P, Jing SQ, Nanduri V, O'Rourke E, Lamballe F, Kovary K, Klein R, Jones KR, Reichardt LF, et al. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell. 1991 Jul 12; 66(1):173-83.
      View in: PubMed
    396. Cordon-Cardo C, O'Brien JP. The multidrug resistance phenotype in human cancer. Important Adv Oncol. 1991; 19-38.
      View in: PubMed
    397. Feickert HJ, Anger BR, Cordon-Cardo C, Lloyd KO. Cell-surface antigens of human lung tumors detected by mouse monoclonal antibodies: definition of blood-group- and non-blood-group-related antigenic systems. Int J Cancer. 1990 Dec 15; 46(6):1007-13.
      View in: PubMed
    398. Bajorin DF, Chapman PB, Wong G, Coit DG, Kunicka J, Dimaggio J, Cordon-Cardo C, Urmacher C, Dantes L, Templeton MA, et al. Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma. Cancer Res. 1990 Dec 1; 50(23):7490-5.
      View in: PubMed
    399. Cordon-Cardo C, Vlodavsky I, Haimovitz-Friedman A, Hicklin D, Fuks Z. Expression of basic fibroblast growth factor in normal human tissues. Lab Invest. 1990 Dec; 63(6):832-40.
      View in: PubMed
    400. Cance WG, Brennan MF, Dudas ME, Huang CM, Cordon-Cardo C. Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med. 1990 Nov 22; 323(21):1457-62.
      View in: PubMed
    401. Houldsworth J, Cordon-Cardo C, Ladanyi M, Kelsen DP, Chaganti RS. Gene amplification in gastric and esophageal adenocarcinomas. Cancer Res. 1990 Oct 1; 50(19):6417-22.
      View in: PubMed
    402. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem. 1990 Sep; 38(9):1277-87.
      View in: PubMed
    403. Sheinfeld J, Cordon-Cardo C, Fair WR, Wartinger DD, Rabinowitz R. Association of type 1 blood group antigens with urinary tract infections in children with genitourinary structural abnormalities. J Urol. 1990 Aug; 144(2 Pt 2):469-73; discussion 474.
      View in: PubMed
    404. Press MF, Cordon-Cardo C, Slamon DJ. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene. 1990 Jul; 5(7):953-62.
      View in: PubMed
    405. Cote RJ, Cordon-Cardo C, Reuter VE, Rosen PP. Immunopathology of adrenal and renal cortical tumors. Coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex. Am J Pathol. 1990 May; 136(5):1077-84.
      View in: PubMed
    406. Sheinfeld J, Reuter VE, Melamed MR, Fair WR, Morse M, Sogani PC, Herr HW, Whitmore WF, Cordon-Cardo C. Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation. J Urol. 1990 Feb; 143(2):285-8.
      View in: PubMed
    407. Sheinfeld J, Cordon-Cardo C, Bander NH. Recent diagnostic modalities for bladder cancer. Immunol Ser. 1990; 53:485-97.
      View in: PubMed
    408. Jaffe EA, Armellino D, Lam G, Cordon-Cardo C, Murray HW, Evans RL. IFN-gamma and IFN-alpha induce the expression and synthesis of Leu 13 antigen by cultured human endothelial cells. J Immunol. 1989 Dec 15; 143(12):3961-6.
      View in: PubMed
    409. Bander NH, Finstad CL, Cordon-Cardo C, Ramsawak RD, Vaughan ED, Whitmore WF, Oettgen HF, Melamed MR, Old LJ. Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas. Cancer Res. 1989 Dec 1; 49(23):6774-80.
      View in: PubMed
    410. Urmacher C, Cordon-Cardo C, Houghton AN. Tissue distribution of GD3 ganglioside detected by mouse monoclonal antibody R24. Am J Dermatopathol. 1989 Dec; 11(6):577-81.
      View in: PubMed
    411. Albino AP, Nanus DM, Mentle IR, Cordon-Cardo C, McNutt NS, Bressler J, Andreeff M. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene. 1989 Nov; 4(11):1363-74.
      View in: PubMed
    412. Mydlo JH, Michaeli J, Cordon-Cardo C, Goldenberg AS, Heston WD, Fair WR. Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res. 1989 Jun 15; 49(12):3407-11.
      View in: PubMed
    413. Bretton PR, Myc A, Cordon-Cardo C, DeAngelis P, Fair WR, Melamed MR. Initial evaluation of a new epithelial antigen (T16) for bivariate flow cytometry of bladder irrigation specimens. Cytometry. 1989 May; 10(3):339-44.
      View in: PubMed
    414. Tanimoto M, Scheinberg DA, Cordon-Cardo C, Huie D, Clarkson BD, Old LJ. Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195. Leukemia. 1989 May; 3(5):339-48.
      View in: PubMed
    415. Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, Rogatko A, Fair WR. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med. 1989 Mar 23; 320(12):773-7.
      View in: PubMed
    416. Cordon-Cardo C, Reuter VE, Finstad CL, Sheinfeld J, Lloyd KO, Fair WR, Melamed MR. Blood group-related antigens in human kidney: modulation of Lewis determinants in renal cell carcinoma. Cancer Res. 1989 Jan 1; 49(1):212-8.
      View in: PubMed
    417. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A. 1989 Jan; 86(2):695-8.
      View in: PubMed
    418. Bazinet M, Cote RJ, Cordon-Cardo C, Myc A, Fair WR, Old LJ. Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen. Cancer Res. 1988 Dec 1; 48(23):6938-42.
      View in: PubMed
    419. Vadhan-Raj S, Cordon-Cardo C, Carswell E, Mintzer D, Dantis L, Duteau C, Templeton MA, Oettgen HF, Old LJ, Houghton AN. Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites. J Clin Oncol. 1988 Oct; 6(10):1636-48.
      View in: PubMed
    420. Motzer RJ, Reuter VE, Cordon-Cardo C, Bosl GJ. Blood group-related antigens in human germ cell tumors. Cancer Res. 1988 Sep 15; 48(18):5342-7.
      View in: PubMed
    421. Cordon-Cardo C, Reuter VE, Lloyd KO, Sheinfeld J, Fair WR, Old LJ, Melamed MR. Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX, and LeY determinants in urothelial carcinoma. Cancer Res. 1988 Jul 15; 48(14):4113-20.
      View in: PubMed
    422. Real FX, Furukawa KS, Mattes MJ, Gusik SA, Cordon-Cardo C, Oettgen HF, Old LJ, Lloyd KO. Class 1 (unique) tumor antigens of human melanoma: identification of unique and common epitopes on a 90-kDa glycoprotein. Proc Natl Acad Sci U S A. 1988 Jun; 85(11):3965-9.
      View in: PubMed
    423. Thomson TM, Real FX, Murakami S, Cordon-Cardo C, Old LJ, Houghton AN. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J Invest Dermatol. 1988 Apr; 90(4):459-66.
      View in: PubMed
    424. Fair WR, Cordon-Cardo C. Immunopathology--new help for the clinician. Semin Urol. 1988 Feb; 6(1):31-45.
      View in: PubMed
    425. Houghton AN, Albino AP, Cordon-Cardo C, Davis LJ, Eisinger M. Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation. J Exp Med. 1988 Jan 1; 167(1):197-212.
      View in: PubMed
    426. Klein CE, Cordon-Cardo C, Soehnchen R, Cote RJ, Oettgen HF, Eisinger M, Old LJ. Changes in cell surface glycoprotein expression during differentiation of human keratinocytes. J Invest Dermatol. 1987 Nov; 89(5):500-6.
      View in: PubMed
    427. Welte K, Miller G, Chapman PB, Yuasa H, Natoli E, Kunicka JE, Cordon-Cardo C, Buhrer C, Old LJ, Houghton AN. Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside. J Immunol. 1987 Sep 15; 139(6):1763-71.
      View in: PubMed
    428. Pumarola-Sune T, Navia BA, Cordon-Cardo C, Cho ES, Price RW. HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol. 1987 May; 21(5):490-6.
      View in: PubMed
    429. Furth ME, Aldrich TH, Cordon-Cardo C. Expression of ras proto-oncogene proteins in normal human tissues. Oncogene. 1987 Mar; 1(1):47-58.
      View in: PubMed
    430. Houghton AN, Real FX, Davis LJ, Cordon-Cardo C, Old LJ. Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells. J Exp Med. 1987 Mar 1; 165(3):812-29.
      View in: PubMed
    431. Cordon-Cardo C, Finstad CL, Bander NH, Melamed MR. Immunoanatomic distribution of cytostructural and tissue-associated antigens in the human urinary tract. Am J Pathol. 1987 Feb; 126(2):269-84.
      View in: PubMed
    432. Cordon-Cardo C. Biochemical and immunologic diagnosis of cancer. Renal and transitional carcinomas. Tumour Biol. 1987; 8(2-3):94-102.
      View in: PubMed
    433. Cordon-Cardo C. Biochemical and immunologic diagnosis of cancer. Melanoma. Tumour Biol. 1987; 8(2-3):151-5.
      View in: PubMed
    434. Cordon-Cardo C, Oettgen HF, Melamed MR. Biochemical and immunologic diagnosis of cancer. Functional histopathology. Tumour Biol. 1987; 8(2-3):177-8.
      View in: PubMed
    435. Tolkoff-Rubin NE, Thompson RE, Piper DJ, Hansen WP, Bander NH, Cordon-Cardo C, Finstad CJ, Klotz LH, Old LJ, Rubin RH. Diagnosis of renal proximal tubular injury by urinary immunoassay for a proximal tubular antigen, the adenosine deaminase binding protein. Nephrol Dial Transplant. 1987; 2(3):143-8.
      View in: PubMed
    436. Collins VP, Cordon-Cardo C. Biochemical and immunologic diagnosis of cancer. Neuroblastoma. Tumour Biol. 1987; 8(2-3):143-6.
      View in: PubMed
    437. Fradet Y, Cordon-Cardo C, Whitmore WF, Melamed MR, Old LJ. Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics. Cancer Res. 1986 Oct; 46(10):5183-8.
      View in: PubMed
    438. Cordon-Cardo C, Lloyd KO, Finstad CL, McGroarty ME, Reuter VE, Bander NH, Old LJ, Melamed MR. Immunoanatomic distribution of blood group antigens in the human urinary tract. Influence of secretor status. Lab Invest. 1986 Oct; 55(4):444-54.
      View in: PubMed
    439. Pumarola-Sune T, Graus F, Chen YX, Cordon-Cardo C, Evans RL. A monoclonal antibody that induces T cell aggregation reacts with vascular endothelial cells and placental trophoblasts. J Immunol. 1986 Aug 1; 137(3):826-9.
      View in: PubMed
    440. Cordon-Cardo C, Lloyd KO, Sakamoto J, McGroarty ME, Old LJ, Melamed MR. Immunohistologic expression of blood-group antigens in normal human gastrointestinal tract and colonic carcinoma. Int J Cancer. 1986 May 15; 37(5):667-76.
      View in: PubMed
    441. Tolkoff-Rubin NE, Cosimi AB, Delmonico FL, Russell PS, Thompson RE, Piper DJ, Hansen WP, Bander NH, Finstad CL, Cordon-Cardo C, et al. Diagnosis of tubular injury in renal transplant patients by a urinary assay for a proximal tubular antigen, the adenosine-deaminase-binding protein. Transplantation. 1986 May; 41(5):593-7.
      View in: PubMed
    442. Sakamoto J, Furukawa K, Cordon-Cardo C, Yin BW, Rettig WJ, Oettgen HF, Old LJ, Lloyd KO. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res. 1986 Mar; 46(3):1553-61.
      View in: PubMed
    443. Houghton AN, Cordon-Cardo C, Eisinger M. Differentiation antigens of melanoma and melanocytes. Int Rev Exp Pathol. 1986; 28:217-48.
      View in: PubMed
    444. Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med. 1986 Jan; 80(1):45-52.
      View in: PubMed
    445. Huffman JL, Fradet Y, Cordon-Cardo C, Herr HW, Pinsky CM, Oettgen HF, Old LJ, Whitmore WF, Melamed MR. Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder. Cancer Res. 1985 Oct; 45(10):5201-4.
      View in: PubMed
    446. Graus F, Cordon-Cardo C, Bonfa E, Elkon KB. Immunohistochemical localization of La nuclear antigen in brain. Selective concentration of the La protein in neuronal nucleoli. J Neuroimmunol. 1985 Sep; 9(5):307-19.
      View in: PubMed
    447. Real FX, Houghton AN, Albino AP, Cordon-Cardo C, Melamed MR, Oettgen HF, Old LJ. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. Cancer Res. 1985 Sep; 45(9):4401-11.
      View in: PubMed
    448. Finstad CL, Cordon-Cardo C, Bander NH, Whitmore WF, Melamed MR, Old LJ. Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proc Natl Acad Sci U S A. 1985 May; 82(9):2955-9.
      View in: PubMed
    449. Rettig WJ, Cordon-Cardo C, Koulos JP, Lewis JL, Oettgen HF, Old LJ. Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodies. Int J Cancer. 1985 Apr 15; 35(4):469-75.
      View in: PubMed
    450. Graus F, Cordon-Cardo C, Posner JB. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology. 1985 Apr; 35(4):538-43.
      View in: PubMed
    451. Bander NH, Cordon-Cardo C, Finstad CL, Whitmore WF, Vaughan ED, Oettgen HF, Melamed M, Old LJ. Immunohistologic dissection of the human kidney using monoclonal antibodies. J Urol. 1985 Mar; 133(3):502-5.
      View in: PubMed
    452. Rettig WJ, Cordon-Cardo C, Ng JS, Oettgen HF, Old LJ, Lloyd KO. High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants. Cancer Res. 1985 Feb; 45(2):815-21.
      View in: PubMed
    453. Houghton AN, Mintzer D, Cordon-Cardo C, Welt S, Fliegel B, Vadhan S, Carswell E, Melamed MR, Oettgen HF, Old LJ. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci U S A. 1985 Feb; 82(4):1242-6.
      View in: PubMed
    454. Cordon-Cardo C, Mattes MJ, Melamed MR, Lewis JL, Old LJ, Lloyd KO. Immunopathologic analysis of a panel of mouse monoclonal antibodies reacting with human ovarian carcinomas and other human tumors. Int J Gynecol Pathol. 1985; 4(2):121-30.
      View in: PubMed
    455. Graus F, Cordon-Cardo C, Houghton AN, Melamed MR, Old LJ. Distribution of the ganglioside GD3 in the human nervous system detected by R24 mouse monoclonal antibody. Brain Res. 1984 Dec 17; 324(1):190-4.
      View in: PubMed
    456. Cordon-Cardo C, Bander NH, Fradet Y, Finstad CL, Whitmore WF, Lloyd KO, Oettgen HF, Melamed MR, Old LJ. Immunoanatomic dissection of the human urinary tract by monoclonal antibodies. J Histochem Cytochem. 1984 Oct; 32(10):1035-40.
      View in: PubMed
    457. Graus F, Cordon-Cardo C, Cho ES, Posner JB. Opsoclonus and oat cell carcinoma of lung: lack of evidence for anti-CNS antibodies. Lancet. 1984 Jun 30; 1(8392):1479.
      View in: PubMed
    458. Fradet Y, Cordon-Cardo C, Thomson T, Daly ME, Whitmore WF, Lloyd KO, Melamed MR, Old LJ. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1984 Jan; 81(1):224-8.
      View in: PubMed
    459. Mattes MJ, Cordon-Cardo C, Lewis JL, Old LJ, Lloyd KO. Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1984 Jan; 81(2):568-72.
      View in: PubMed
    460. Razin E, Rifkind AB, Cordon-Cardo C, Good RA. Selective growth of a population of human basophil cells in vitro. Proc Natl Acad Sci U S A. 1981 Sep; 78(9):5793-6.
      View in: PubMed
    461. Razin E, Cordon-Cardo C, Good RA. Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. Proc Natl Acad Sci U S A. 1981 Apr; 78(4):2559-61.
      View in: PubMed
    Cordon-Cardo's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067